https://primarycare.designagency.gr/ekpedeytika-seminaria-2017/2017-08-08T13:48:51+02:00https://primarycare.designagency.gr/8o-panellinio-seminario/2017-08-08T13:58:22+02:00https://primarycare.designagency.gr/chimerino-ekpedevtiko-seminario/2017-08-08T13:57:21+02:00https://primarycare.designagency.gr/earino-kliniko-frontistirio/2017-08-08T14:14:17+02:00https://primarycare.designagency.gr/7o-panellhnio-seminario/2017-08-08T14:21:01+02:00https://primarycare.designagency.gr/11o-polythematiko-metekpaedeytiko-seminario/2017-08-08T14:01:59+02:00https://primarycare.designagency.gr/10o-panellinio-polythematiko-metekpedeytiko-seminario-protovathmias-frontidas-ygeias/2017-08-08T15:03:13+02:00https://primarycare.designagency.gr/xeimerino-ekpedeytiko-seminario-protovathmias-frontidas-ygias/2017-08-08T15:01:48+02:00https://primarycare.designagency.gr/1o-therino-scholio-protovathmias-frontidas-ygias/2017-08-08T15:16:53+02:00https://primarycare.designagency.gr/6o-panellinio-seminario-omadon-ergasias-stin-protovathmias-frontidas-ygias/2017-08-08T15:27:47+02:00https://primarycare.designagency.gr/5o-panellinio-seminario-omadon-ergasias-stin-protovathmias-frontidas-ygias/2017-08-08T15:36:48+02:00https://primarycare.designagency.gr/earino-ekpedevtiko-seminario-protovathmias-frontidas-ygias/2017-08-08T15:42:06+02:00https://primarycare.designagency.gr/kliniko-frontistirio-protovathmias-frontidas-ygias/2017-08-08T15:50:33+02:00https://primarycare.designagency.gr/kliniko-frontistirio-apo-ti-theoria-stin-praxi/2017-08-08T15:57:23+02:00https://primarycare.designagency.gr/kliniko-frontistirio-protovathmias-frontidas-ygias-2013/2017-08-08T16:07:20+02:00https://primarycare.designagency.gr/2o-panellinio-kliniko-frontistirio-sti-diachirisi-metavolikon-nosimaton-stin-protovathmia-frontida-ygias/2017-08-08T16:24:18+02:00https://primarycare.designagency.gr/4o-panellinio-seminario-omadon-ergasias-stin-protovathmias-frontidas-ygias/2017-08-08T16:29:38+02:00https://primarycare.designagency.gr/earino-ekpedevtiko-seminario/2017-08-08T16:34:44+02:00https://primarycare.designagency.gr/chimerino-ekpedevtiko-seminario-2013/2017-08-08T16:40:28+02:00https://primarycare.designagency.gr/7o-polythematiko-metekpedevtiko-seminario-protovathmias-frontidas-ygias/2017-08-08T16:51:18+02:00https://primarycare.designagency.gr/diagnostiki-ke-therapevtiki-provlimatismi-gia-ti-chronia-apofraktiki-pnevmonopathia-sti-protovathmia-frontida-ygias/2017-08-08T16:58:42+02:00https://primarycare.designagency.gr/1o-panellinio-kliniko-seminario-diaxhirisi-metavolion-nosimaton-stin-pfy/2017-08-08T17:59:28+02:00https://primarycare.designagency.gr/1o-makedoniko-seminario-stin-protovathmia-frontida-ygias/2017-08-09T12:13:24+02:00https://primarycare.designagency.gr/1o-kykladitiko-seminario-stin-protovathmias-frontidas-ygias/2017-08-09T12:19:02+02:00https://primarycare.designagency.gr/therino-ekpedevtiko-seminario/2017-08-09T12:30:41+02:00https://primarycare.designagency.gr/2o-panellinio-seminario-omadon-ergasias-tis-e-e-e-e-p/2017-08-09T12:40:06+02:00https://primarycare.designagency.gr/chimerino-ekpedevtiko-seminario-2011/2018-01-11T18:50:49+02:00https://primarycare.designagency.gr/earino-ekpedevtiko-seminario-2/2017-08-09T13:15:52+02:00https://primarycare.designagency.gr/ekpedevtiko-seminario/2017-08-09T13:23:44+02:00https://primarycare.designagency.gr/chimerino-ekpedevtiko-seminario-2010/2017-08-09T15:16:46+02:00https://primarycare.designagency.gr/1o-panellinio-seminario-omadon-ergasias-tis-e-e-e-e-p/2017-08-09T15:23:58+02:00https://primarycare.designagency.gr/5o-polythematiko-metekpedevtiko-seminario-protovathmias-frontidas-ygias/2017-08-09T15:29:31+02:00https://primarycare.designagency.gr/chimerino-ekpedevtiko-seminario-2009/2017-08-09T15:55:49+02:00https://primarycare.designagency.gr/ygia-ton-arthroseon-pos-na-veltiosete-tin-kathimerini-sas-kinisi/2017-09-28T15:19:16+02:00https://primarycare.designagency.gr/ipcrg-1st-south-asian-scientific-congress/2017-09-30T11:16:01+02:00https://primarycare.designagency.gr/ekpedeftika-seminaria-2018-e-e-e-e-p/2017-10-04T22:11:20+02:00https://primarycare.designagency.gr/epistimonikes-ekdilosis-2018-e-k-o-g-i/2017-10-04T22:22:03+02:00https://primarycare.designagency.gr/4o-panellinio-lemfologiko-synedrio/2018-02-14T11:35:09+02:00https://primarycare.designagency.gr/4o-panellinio-lemfologiko-synedrio-2/2018-03-12T17:02:16+02:00https://primarycare.designagency.gr/oyrologiko-seminario-sti-pfy/2018-04-22T21:34:25+02:00https://primarycare.designagency.gr/therino-ekpaideytiko-seminario-eeeep-poros/2018-06-08T17:08:37+02:00https://primarycare.designagency.gr/kampania-enimerosis-enjoy-summer-enjoy-sex-enjoy-safe-sex/2018-10-16T22:14:53+02:00https://primarycare.designagency.gr/7o-panellinio-synedrio-ekogi/2018-06-20T17:43:47+02:00https://primarycare.designagency.gr/prokiryxi-toy-metaptychiakoy-programmatos-spoydon/2018-07-23T18:53:15+02:00https://primarycare.designagency.gr/prokiryxi-metaptychiakoy-programmatos-attikon/2018-09-04T20:14:34+02:00https://primarycare.designagency.gr/kliniko-frontistirio-ekogi-pella/2018-10-16T22:38:52+02:00https://primarycare.designagency.gr/panellinio-polythematiko-seminario-eeeep-arachova/2018-11-19T08:53:42+02:00https://primarycare.designagency.gr/i-machi-enantia-sto-kryologima-kai-ti-gripi/2018-12-20T01:33:22+02:00https://primarycare.designagency.gr/gilenya-fingkolimodi-nea-antendeixi-se-egkyes-gynaikes/2019-10-02T13:32:39+02:00https://primarycare.designagency.gr/ekpaideytika-seminaria-2020/2019-10-16T00:15:37+02:00https://primarycare.designagency.gr/14o-panellinio-polythematiko-seminario-pfy/2019-11-11T21:56:27+02:00https://primarycare.designagency.gr/diadrastiko-webinar-e-symposium/2020-06-12T18:40:24+02:00https://primarycare.designagency.gr/15o-panellinio-polythematiko-seminario-pfy/2020-09-14T16:18:55+02:00https://primarycare.designagency.gr/data-on-14-day-notification-rate-of-new-covid-19-cases-and-deaths/2021-02-25T08:41:20+02:00https://primarycare.designagency.gr/sars-cov-2-in-mink-recommendations-to-improve-monitoring/2021-02-25T08:41:20+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-14-20-february-2021-week-7/2021-02-25T08:41:20+02:00https://primarycare.designagency.gr/data-on-country-response-measures-to-covid-19/2021-02-25T08:41:20+02:00https://primarycare.designagency.gr/data-on-testing-for-covid-19-by-week-and-country/2021-02-25T08:41:21+02:00https://primarycare.designagency.gr/data-on-hospital-and-icu-admission-rates-and-current-occupancy-for-covid-19/2021-02-25T08:41:21+02:00https://primarycare.designagency.gr/data-on-the-daily-subnational-14-day-notification-rate-of-new-covid-19-cases/2021-02-25T08:41:21+02:00https://primarycare.designagency.gr/data-on-the-weekly-subnational-14-day-notification-rate-of-new-covid-19-cases/2021-02-25T08:41:21+02:00https://primarycare.designagency.gr/data-for-the-maps-in-support-of-the-council-recommendation-on-a-coordinated-approach-to-the-restriction-of-free-movement-in-response-to-the-covid-19-pandemic-in-the-eu-eea/2021-02-25T08:41:21+02:00https://primarycare.designagency.gr/detailed-data-on-covid-19-vaccination-progress-in-the-eu-eea-available-via-vaccine-tracker-and-in-weekly-reports/2021-02-25T08:41:21+02:00https://primarycare.designagency.gr/methods-for-the-detection-and-identification-of-sars-cov-2-variants/2021-03-03T13:34:46+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-28-february-6-march-2021-week-9/2021-03-05T14:40:50+02:00https://primarycare.designagency.gr/help-slow-the-spread-of-covid-19%e2%80%8b-wear-a-face-mask/2021-03-09T11:35:50+02:00https://primarycare.designagency.gr/covid-19-vaccine-tracker/2021-03-11T19:34:52+02:00https://primarycare.designagency.gr/one-day-in-action-review-iar-protocol-in-the-context-of-covid-19/2021-03-12T15:34:44+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-7-13-march-2021-week-10/2021-03-12T16:40:37+02:00https://primarycare.designagency.gr/guidance-for-covid-19-quarantine-and-testing-of-travellers/2021-03-12T17:36:26+02:00https://primarycare.designagency.gr/introducing-a-coherent-european-framework-for-tuning-covid-19-response-measures/2021-03-17T16:36:11+02:00https://primarycare.designagency.gr/considerations-on-the-use-of-self-tests-for-covid-19-in-the-eu-eea/2021-03-17T17:35:25+02:00https://primarycare.designagency.gr/data-on-the-daily-number-of-new-reported-covid-19-cases-and-deaths-by-eu-eea-country/2021-03-17T18:36:54+02:00https://primarycare.designagency.gr/stress-test-on-logistical-aspects-of-covid-19-vaccination-deployment-plans-for-the-western-balkans-final-report/2021-03-18T10:42:23+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-14-20-march-2021-week-11/2021-03-19T13:34:45+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-21-27-march-2021-week-12/2021-03-26T16:35:29+02:00https://primarycare.designagency.gr/rollout-of-covid-19-vaccines-in-the-eu-eea-challenges-and-good-practice/2021-03-29T10:34:57+02:00https://primarycare.designagency.gr/overview-of-the-implementation-of-covid-19-vaccination-strategies-and-vaccine-deployment-plans-in-the-eu-eea/2021-03-29T15:36:51+02:00https://primarycare.designagency.gr/risk-of-sars-cov-2-transmission-from-newly-infected-individuals-with-documented-previous-infection-or-vaccination/2021-03-29T16:42:01+02:00https://primarycare.designagency.gr/ecdc-report-examines-sars-cov-2-transmission-risk-from-vaccinated-previously-infected-individuals/2021-03-29T16:42:01+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-28-march-3-april-2021-week-13/2021-04-01T12:35:33+02:00https://primarycare.designagency.gr/reinfection-with-sars-cov-2-implementation-of-a-surveillance-case-definition-within-the-eu-eea/2021-04-08T10:37:25+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-4-10-april-2021-week-14/2021-04-09T14:38:13+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-11-17-april-2021-week-15/2021-04-16T14:35:08+02:00https://primarycare.designagency.gr/infographic-mutation-of-sars-cov2-current-variants-of-concern/2021-04-20T17:34:36+02:00https://primarycare.designagency.gr/vaxzevria-emvolio-tis-astrazeneca-enanti-tis-nosoy-covid-19/2021-04-21T11:19:19+02:00https://primarycare.designagency.gr/ecdc-guidance-for-adjusting-non-pharmaceutical-interventions-based-on-vaccination-status/2021-04-21T17:38:24+02:00https://primarycare.designagency.gr/interim-guidance-on-the-benefits-of-full-vaccination-against-covid-19-for-transmission-and-implications-for-non-pharmaceutical-interventions/2021-04-21T17:38:24+02:00https://primarycare.designagency.gr/forecasting-covid-19-cases-and-deaths-in-europe-new-hub-will-support-european-pandemic-planning/2021-04-22T10:35:37+02:00https://primarycare.designagency.gr/data-on-sars-cov-2-variants-in-the-eu-eea/2021-04-22T14:35:30+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-18-24-april-2021-week-16/2021-04-23T14:35:12+02:00https://primarycare.designagency.gr/objectives-of-vaccination-strategies-against-covid-19/2021-04-23T16:34:38+02:00https://primarycare.designagency.gr/infographic-covid-19-vaccination-in-the-eu-eea/2021-04-26T09:34:48+02:00https://primarycare.designagency.gr/ema-and-ecdc-join-forces-for-enhanced-post-marketing-monitoring-of-covid-19-vaccines-in-europe/2021-04-26T16:34:52+02:00https://primarycare.designagency.gr/sars-cov-2-variants-of-concern-pose-a-higher-risk-for-hospitalisation-and-intensive-care-admission/2021-04-28T10:34:41+02:00https://primarycare.designagency.gr/european-immunization-week-2021/2021-04-29T08:35:45+02:00https://primarycare.designagency.gr/archive-of-data-for-the-maps-in-support-of-the-council-recommendation-on-a-coordinated-approach-to-travel-measures-in-the-eu/2021-04-30T10:35:24+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-25-april-1-may-2021-week-17/2021-04-30T15:35:00+02:00https://primarycare.designagency.gr/considerations-for-the-use-of-saliva-as-sample-material-for-covid-19-testing/2021-05-03T13:35:44+02:00https://primarycare.designagency.gr/guidance-for-representative-and-targeted-genomic-sars-cov-2-monitoring/2021-05-03T15:34:48+02:00https://primarycare.designagency.gr/infographic-rapid-antigen-tests-for-sars-cov-2-in-the-workplace/2021-05-06T10:34:57+02:00https://primarycare.designagency.gr/stop-the-spread-could-diagnostic-antigen-tests-help-control-covid-19-transmission-in-workplaces/2021-05-06T10:34:57+02:00https://primarycare.designagency.gr/considerations-on-the-use-of-rapid-antigen-detection-including-self-tests-for-sars-cov-2-in-occupational-settings/2021-05-06T10:34:57+02:00https://primarycare.designagency.gr/data-collection-on-covid-19-outbreaks-in-closed-settings-a-with-completed-vaccination-programme-long-term-care-facilities/2021-05-06T17:35:51+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-2-8-may-2021-week-18/2021-05-07T13:36:39+02:00https://primarycare.designagency.gr/data-on-covid-19-vaccination-in-the-eu-eea/2021-05-10T14:37:34+02:00https://primarycare.designagency.gr/threat-assessment-brief-emergence-of-sars-cov-2-b-1-617-variants-in-india-and-situation-in-the-eu-eea/2021-05-11T20:35:37+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-9-15-may-2021-week-19/2021-05-12T13:40:33+02:00https://primarycare.designagency.gr/overview-of-eu-eea-country-recommendations-on-covid-19-vaccination-with-vaxzevria-and-a-scoping-review-of-evidence-to-guide-decision-making/2021-05-18T15:36:56+02:00https://primarycare.designagency.gr/ecdc-releases-new-dashboard-on-sars-cov-2-variants/2021-05-19T10:36:56+02:00https://primarycare.designagency.gr/public-health-impact-of-sars-cov-2-variants-of-concern-scoping-review-protocol/2021-05-20T09:35:06+02:00https://primarycare.designagency.gr/the-use-of-antibody-tests-for-sars-cov-2-in-the-context-of-digital-green-certificates/2021-05-20T13:35:06+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-16-22-may-2021-week-20/2021-05-21T13:35:22+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-23-29-may-2021-week-21/2021-05-28T14:34:51+02:00https://primarycare.designagency.gr/infographic-considerations-for-vaccinating-adolescents-against-covid-19/2021-06-01T12:34:54+02:00https://primarycare.designagency.gr/ecdc-report-outlines-considerations-for-covid-19-vaccination-of-adolescents/2021-06-01T12:34:54+02:00https://primarycare.designagency.gr/interim-public-health-considerations-for-covid-19-vaccination-of-adolescents-in-the-eu-eea/2021-06-01T12:34:54+02:00https://primarycare.designagency.gr/suspected-adverse-reactions-to-covid-19-vaccination-and-the-safety-of-substances-of-human-origin/2021-06-03T10:34:34+02:00https://primarycare.designagency.gr/infographic-reducing-covid-19-transmission-and-strengthening-vaccine-uptake-among-migrants/2021-06-03T10:34:34+02:00https://primarycare.designagency.gr/infographic-findings-on-covid-19-transmission-and-vaccine-uptake-among-migrants/2021-06-03T10:34:34+02:00https://primarycare.designagency.gr/reducing-covid-19-transmission-and-strengthening-vaccine-uptake-among-migrant-populations-in-the-eu-eea/2021-06-03T10:34:34+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-30-may-5-june-2021-week-22/2021-06-04T14:34:40+02:00https://primarycare.designagency.gr/video-tutorial-on-how-to-report-covid-19-cases-to-ecdc-via-tessy/2021-06-10T09:35:32+02:00https://primarycare.designagency.gr/e-learning-covid-19-infection-prevention-and-control/2021-06-10T09:35:32+02:00https://primarycare.designagency.gr/rapid-risk-assessment-assessing-sars-cov-2-circulation-variants-of-concern-non-pharmaceutical-interventions-and-vaccine-rollout-in-the-eu-eea-15th-update/2021-06-10T10:34:33+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-6-12-june-2021-week-23/2021-06-11T13:35:30+02:00https://primarycare.designagency.gr/overview-of-the-implementation-of-covid-19-vaccination-strategies-and-deployment-plans-in-the-eu-eea/2021-06-14T12:34:35+02:00https://primarycare.designagency.gr/ecdc-begins-epidemic-monitoring-of-the-euro-2020-2021-football-championship/2021-06-15T16:35:09+02:00https://primarycare.designagency.gr/ecdc-supports-eu-eea-member-states-in-rapid-detection-of-sars-cov-2-variants/2021-06-16T09:34:59+02:00https://primarycare.designagency.gr/easa-ecdc-update-air-travel-guidelines-to-factor-in-vaccination-and-latest-scientific-evidence/2021-06-17T11:35:24+02:00https://primarycare.designagency.gr/covid-19-aviation-health-safety-protocol-operational-guidelines-for-the-management-of-air-passengers-and-aviation-personnel-in-relation-to-the-covid-19-pandemic/2021-06-17T11:35:25+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-13-19-june-2021-week-24/2021-06-18T15:34:43+02:00https://primarycare.designagency.gr/webinar-best-practices-on-increasing-covid-19-vaccination-uptake-in-vulnerable-populations/2021-06-22T13:35:06+02:00https://primarycare.designagency.gr/sars-cov-2-delta-variant-full-vaccination-is-needed-to-protect-the-vulnerable/2021-06-23T15:35:21+02:00https://primarycare.designagency.gr/threat-assessment-brief-implications-for-the-eu-eea-on-the-spread-of-the-sars-cov-2-delta-b-1-617-2-variant-of-concern/2021-06-23T15:35:22+02:00https://primarycare.designagency.gr/video-ecdc-statement-on-the-sars-cov-2-delta-variant-in-the-eu-eea/2021-06-23T17:35:00+02:00https://primarycare.designagency.gr/ecdc-statement-on-the-sars-cov-2-delta-variant-in-the-eu-eea/2021-06-23T17:35:00+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-20-26-june-2021-week-25/2021-06-24T14:37:20+02:00https://primarycare.designagency.gr/who-and-ecdc-launch-indicator-framework-to-evaluate-the-public-health-effectiveness-of-digital-proximity-tracing-solutions/2021-06-28T10:34:39+02:00https://primarycare.designagency.gr/indicator-framework-to-evaluate-the-public-health-effectiveness-of-digital-proximity-tracing-solutions/2021-06-28T12:35:46+02:00https://primarycare.designagency.gr/factsheet-countering-online-vaccine-misinformation-in-the-eu-eea/2021-06-29T14:34:37+02:00https://primarycare.designagency.gr/infographic-countering-online-vaccine-misinformation/2021-06-29T14:34:37+02:00https://primarycare.designagency.gr/ecdc-launches-the-report-countering-online-vaccine-misinformation-in-the-eu-eea/2021-06-29T14:34:37+02:00https://primarycare.designagency.gr/countering-online-vaccine-misinformation-in-the-eu-eea/2021-06-29T14:34:37+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-27-june-3-july-2021-week-26/2021-07-02T14:34:43+02:00https://primarycare.designagency.gr/covid-19-in-children-and-the-role-of-school-settings-in-transmission-second-update/2021-07-08T14:34:43+02:00https://primarycare.designagency.gr/covid-19-in-children-and-the-role-of-school-settings-in-transmission-second-update-2/2021-07-08T14:34:44+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-4-10-july-2021-week-27/2021-07-09T15:37:00+02:00https://primarycare.designagency.gr/positivity-rates-updated-8-july-2021/2021-07-13T10:34:52+02:00https://primarycare.designagency.gr/combined-indicator-14-day-notification-rate-testing-rate-and-test-positivity-updated-8-july-2021-week-26/2021-07-13T10:34:52+02:00https://primarycare.designagency.gr/combined-indicator-14-day-notification-rate-testing-rate-and-test-positivity-updated-8-july-2021-week-26-colour-blind-friendly/2021-07-13T11:38:35+02:00https://primarycare.designagency.gr/testing-rates-per-100-000-inhabitants-updated-8-july-2021-week-26/2021-07-13T12:34:46+02:00https://primarycare.designagency.gr/combined-indicator-14-day-notification-rate-testing-rate-and-test-positivity-updated-3-june-2021-week-21-colour-blind-friendly/2021-07-13T16:34:36+02:00https://primarycare.designagency.gr/14-day-case-notification-rate-per-100-000-inhabitants-updated-8-july-2021-weeks-25-26/2021-07-14T10:36:40+02:00https://primarycare.designagency.gr/14-day-case-notification-rate-per-100-000-inhabitants-updated-17-december-2020-week-49-50/2021-07-14T13:34:36+02:00https://primarycare.designagency.gr/14-day-case-notification-rate-per-100-000-inhabitants-updated-14-january-2021-weeks-0-1/2021-07-14T13:34:36+02:00https://primarycare.designagency.gr/ema-and-ecdc-update-on-covid-19/2021-07-14T16:35:54+02:00https://primarycare.designagency.gr/positivity-rates-updated-8-july-2021-week-26/2021-07-14T17:37:31+02:00https://primarycare.designagency.gr/combined-indicator-14-day-notification-rate-testing-rate-and-test-positivity-updated-8-july-2021-week-26-2/2021-07-14T18:34:52+02:00https://primarycare.designagency.gr/combined-indicator-14-day-notification-rate-testing-rate-and-test-positivity-updated-15-july-2021-weeks-26-27/2021-07-15T14:36:33+02:00https://primarycare.designagency.gr/positivity-rates-updated-15-july-2021-week-27/2021-07-15T15:34:41+02:00https://primarycare.designagency.gr/testing-rates-per-100-000-inhabitants-updated-15-july-2021-week-27/2021-07-15T15:34:41+02:00https://primarycare.designagency.gr/14-day-case-notification-rate-per-100-000-inhabitants-updated-15-july-2021-weeks-26-27/2021-07-15T15:34:41+02:00https://primarycare.designagency.gr/combined-indicator-14-day-notification-rate-testing-rate-and-test-positivity-updated-15-july-2021-colour-blind-friendly-weeks-26-27/2021-07-15T15:34:41+02:00https://primarycare.designagency.gr/combined-indicator-14-day-notification-rate-testing-rate-and-test-positivity-updated-15-july-2021-weeks-26-27-2/2021-07-15T17:35:17+02:00https://primarycare.designagency.gr/sars-cov-2-resurgence-in-eu-and-eea-related-to-relaxation-of-non-pharmaceutical-interventions-and-increasing-spread-of-delta-variant/2021-07-16T08:35:18+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-11-17-july-2021-week-28/2021-07-16T15:35:38+02:00https://primarycare.designagency.gr/partial-covid-19-vaccination-vaccination-following-sars-cov-2-infection-and-heterologous-vaccination-schedule-summary-of-evidence/2021-07-22T11:34:44+02:00https://primarycare.designagency.gr/positivity-rates-updated-22-july-2021-week-28/2021-07-22T13:34:38+02:00https://primarycare.designagency.gr/testing-rates-per-100-000-inhabitants-updated-22-july-2021-week-28/2021-07-22T13:34:38+02:00https://primarycare.designagency.gr/14-day-case-notification-rate-per-100-000-inhabitants-updated-22-july-2021-weeks-27-28/2021-07-22T13:34:38+02:00https://primarycare.designagency.gr/combined-indicator-14-day-notification-rate-testing-rate-and-test-positivity-updated-22-july-2021-weeks-27-28/2021-07-22T13:34:38+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-18-24-july-2021-week-29/2021-07-23T16:35:10+02:00https://primarycare.designagency.gr/rapid-risk-assessment-covid-19-outbreaks-in-long-term-care-facilities-in-the-eu-eea-in-the-context-of-current-vaccination-coverage/2021-07-26T13:37:22+02:00https://primarycare.designagency.gr/ecdc-rapid-risk-assessment-several-recent-covid-19-outbreaks-in-long-term-care-facilities-in-the-eu-eea/2021-07-26T14:37:20+02:00https://primarycare.designagency.gr/combined-indicator-14-day-notification-rate-testing-rate-and-test-positivity-updated-29-july-2021-colour-blind-friendly/2021-07-29T13:34:43+02:00https://primarycare.designagency.gr/combined-indicator-14-day-notification-rate-testing-rate-and-test-positivity-updated-29-july-2021/2021-07-29T13:34:43+02:00https://primarycare.designagency.gr/positivity-rates-updated-29-july-2021-week-29/2021-07-29T14:35:30+02:00https://primarycare.designagency.gr/testing-rates-per-100-000-inhabitants-updated-29-july-2021-week-29/2021-07-29T14:35:30+02:00https://primarycare.designagency.gr/14-day-case-notification-rate-per-100-000-inhabitants-updated-29-july-2021-weeks-28-29/2021-07-29T14:35:30+02:00https://primarycare.designagency.gr/combined-indicator-14-day-notification-rate-testing-rate-and-test-positivity-updated-29-july-2021-weeks-28-29/2021-07-29T14:35:30+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-25-31-july-2021-week-30/2021-07-30T15:36:45+02:00https://primarycare.designagency.gr/ecdc-and-ema-update-on-covid-19/2021-08-04T14:42:27+02:00https://primarycare.designagency.gr/testing-rates-per-100-000-inhabitants-updated-5-august-2021-week-30/2021-08-05T12:39:03+02:00https://primarycare.designagency.gr/positivity-rates-updated-5-august-2021-week-30/2021-08-05T12:39:03+02:00https://primarycare.designagency.gr/14-day-case-notification-rate-per-100-000-inhabitants-updated-5-august-2021-weeks-29-30/2021-08-05T12:39:03+02:00https://primarycare.designagency.gr/combined-indicator-14-day-notification-rate-testing-rate-and-test-positivity-updated-5-august-2021-weeks-29-30/2021-08-05T12:39:03+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-1-7-august-week-31/2021-08-06T16:36:39+02:00https://primarycare.designagency.gr/o-pagkosmios-organismos-ygeias-synista-ivoyprofaini-kai-aspirini-gia-tin-antimetopisi-ton-ipion-anepithymiton-energeion-toy-emvolioy-kata-tis-covid-19/2021-08-09T10:51:02+02:00https://primarycare.designagency.gr/covid-19-vaccine-tracker-update-released/2021-08-12T11:35:39+02:00https://primarycare.designagency.gr/combined-indicator-14-day-notification-rate-testing-rate-and-test-positivity-updated-12-august-2021-colour-blind-friendly-weeks-30-31/2021-08-12T12:37:18+02:00https://primarycare.designagency.gr/positivity-rates-updated-12-august-2021-week-31/2021-08-12T12:37:18+02:00https://primarycare.designagency.gr/testing-rates-per-100-000-inhabitants-updated-12-august-2021-week-31/2021-08-12T12:37:18+02:00https://primarycare.designagency.gr/14-day-case-notification-rate-per-100-000-inhabitants-updated-12-august-2021-weeks-30-31/2021-08-12T12:37:18+02:00https://primarycare.designagency.gr/combined-indicator-14-day-notification-rate-testing-rate-and-test-positivity-updated-12-august-2021-weeks-30-31/2021-08-12T12:37:18+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-8-14-august-week-32/2021-08-13T14:36:34+02:00https://primarycare.designagency.gr/combined-indicator-14-day-notification-rate-testing-rate-and-test-positivity-updated-19-august-2021-colour-blind-friendly-weeks-31-32/2021-08-19T12:36:56+02:00https://primarycare.designagency.gr/testing-rates-per-100-000-inhabitants-updated-19-august-2021-week-32/2021-08-19T12:36:56+02:00https://primarycare.designagency.gr/combined-indicator-14-day-notification-rate-testing-rate-and-test-positivity-updated-19-august-2021-weeks-31-32/2021-08-19T12:36:56+02:00https://primarycare.designagency.gr/positivity-rates-updated-12-august-2021-week-32/2021-08-19T12:36:56+02:00https://primarycare.designagency.gr/14-day-case-notification-rate-per-100-000-inhabitants-updated-19-august-2021-weeks-31-32/2021-08-19T12:36:56+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-15-21-august-week-33/2021-08-20T15:37:28+02:00https://primarycare.designagency.gr/positivity-rates-updated-26-august-2021-week-33/2021-08-26T16:36:28+02:00https://primarycare.designagency.gr/testing-rates-per-100-000-inhabitants-updated-26-august-2021-week-33/2021-08-26T16:36:28+02:00https://primarycare.designagency.gr/14-day-case-notification-rate-per-100-000-inhabitants-updated-26-august-2021-weeks-32-33/2021-08-26T16:36:28+02:00https://primarycare.designagency.gr/combined-indicator-14-day-notification-rate-testing-rate-and-test-positivity-updated-26-august-2021-weeks-32-33/2021-08-26T16:36:28+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-22-28-august-week-34/2021-08-27T15:35:41+02:00https://primarycare.designagency.gr/interim-public-health-considerations-for-the-provision-of-additional-covid-19-vaccine-doses/2021-09-01T19:34:38+02:00https://primarycare.designagency.gr/ecdc-and-ema-highlight-considerations-for-additional-and-booster-doses-of-covid-19-vaccines/2021-09-02T10:35:33+02:00https://primarycare.designagency.gr/positivity-rates-updated-2-september-2021-week-34/2021-09-02T15:35:34+02:00https://primarycare.designagency.gr/testing-rates-per-100-000-inhabitants-updated-2-september-2021-week-34/2021-09-02T15:35:34+02:00https://primarycare.designagency.gr/14-day-case-notification-rate-per-100-000-inhabitants-updated-2-september-2021-weeks-33-34/2021-09-02T15:35:34+02:00https://primarycare.designagency.gr/combined-indicator-14-day-notification-rate-testing-rate-and-test-positivity-updated-2-september-2021-colour-blind-friendly-weeks-33-34/2021-09-02T15:35:34+02:00https://primarycare.designagency.gr/combined-indicator-14-day-notification-rate-testing-rate-and-test-positivity-updated-2-september-2021-weeks-33-34/2021-09-02T15:35:34+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-29-august-4-september-week-35/2021-09-03T13:40:07+02:00https://primarycare.designagency.gr/ecdc-awards-77-me-to-strengthen-eu-eea-member-states-capacities-to-detect-and-identify-sars-cov-2-variants/2021-09-03T13:40:07+02:00https://primarycare.designagency.gr/combined-indicator-14-day-notification-rate-testing-rate-and-test-positivity-updated-9-september-2021-weeks-34-35/2021-09-09T15:37:44+02:00https://primarycare.designagency.gr/testing-rates-per-100-000-inhabitants-updated-9-september-2021-week-35/2021-09-09T16:34:43+02:00https://primarycare.designagency.gr/positivity-rates-updated-9-september-2021-week-35/2021-09-09T16:34:43+02:00https://primarycare.designagency.gr/14-day-case-notification-rate-per-100-000-inhabitants-updated-9-september-2021-weeks-34-35/2021-09-09T16:34:44+02:00https://primarycare.designagency.gr/14-day-case-notification-rate-per-100-000-inhabitants-updated-9-september-2021-weeks-34-35-2/2021-09-09T16:34:44+02:00https://primarycare.designagency.gr/combined-indicator-14-day-notification-rate-testing-rate-and-test-positivity-updated-9-september-2021-colour-blind-friendly-weeks-34-35/2021-09-09T16:34:44+02:00https://primarycare.designagency.gr/combined-indicator-14-day-notification-rate-testing-rate-and-test-positivity-updated-9-september-2021-colour-blind-friendly-weeks-34-35-2/2021-09-09T16:34:44+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-5-11-september-week-36/2021-09-10T14:36:19+02:00https://primarycare.designagency.gr/1o-panellinio-synedrio-efarmogon-pliroforikis/2021-09-13T23:00:46+02:00https://primarycare.designagency.gr/16o-panellinio-polythematiko-synedrio/2021-09-15T11:12:42+02:00https://primarycare.designagency.gr/positivity-rates-updated-16-september-2021-week-36/2021-09-16T15:35:43+02:00https://primarycare.designagency.gr/testing-rates-per-100-000-inhabitants-updated-16-september-2021-week-36/2021-09-16T15:35:43+02:00https://primarycare.designagency.gr/14-day-case-notification-rate-per-100-000-inhabitants-updated-16-september-2021-weeks-35-36/2021-09-16T15:35:43+02:00https://primarycare.designagency.gr/combined-indicator-14-day-notification-rate-testing-rate-and-test-positivity-updated-16-september-2021-colour-blind-friendly-weeks-35-36/2021-09-16T15:35:43+02:00https://primarycare.designagency.gr/combined-indicator-14-day-notification-rate-testing-rate-and-test-positivity-updated-16-september-2021-weeks-35-36/2021-09-16T15:35:43+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-12-18-september-2021-week-37/2021-09-17T15:36:51+02:00https://primarycare.designagency.gr/protocol-for-a-focused-after-action-review-on-evidence-based-decision-making-for-selected-covid-19-response-measures/2021-09-22T11:34:55+02:00https://primarycare.designagency.gr/positivity-rates-updated-23-september-2021-week-37/2021-09-23T12:37:02+02:00https://primarycare.designagency.gr/testing-rates-per-100-000-inhabitants-updated-23-september-2021-week-37/2021-09-23T12:37:02+02:00https://primarycare.designagency.gr/14-day-case-notification-rate-per-100-000-inhabitants-updated-23-september-2021-weeks-36-37/2021-09-23T12:37:02+02:00https://primarycare.designagency.gr/combined-indicator-14-day-notification-rate-testing-rate-and-test-positivity-updated-23-september-2021-colour-blind-friendly-weeks-36-37/2021-09-23T12:37:02+02:00https://primarycare.designagency.gr/combined-indicator-14-day-notification-rate-testing-rate-and-test-positivity-updated-23-september-2021-weeks-36-37/2021-09-23T12:37:02+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-19-25-september-2021-week-38/2021-09-24T15:37:57+02:00https://primarycare.designagency.gr/rapid-risk-assessment-assessing-sars-cov-2-circulation-variants-of-concern-non-pharmaceutical-interventions-and-vaccine-rollout-in-the-eu-eea-16th-update/2021-09-30T16:35:01+02:00https://primarycare.designagency.gr/testing-rates-per-100-000-inhabitants-updated-30-september-2021/2021-09-30T16:35:01+02:00https://primarycare.designagency.gr/14-day-case-notification-rate-per-100-000-inhabitants-updated-30-september-2021/2021-09-30T16:35:01+02:00https://primarycare.designagency.gr/combined-indicator-14-day-notification-rate-testing-rate-and-test-positivity-updated-23-september-2021-colour-blind-friendly/2021-09-30T16:35:01+02:00https://primarycare.designagency.gr/combined-indicator-14-day-notification-rate-testing-rate-and-test-positivity-updated-30-september-2021/2021-09-30T16:35:01+02:00https://primarycare.designagency.gr/positivity-rates-updated-30-september-2021/2021-09-30T16:35:01+02:00https://primarycare.designagency.gr/high-risk-of-autumn-surge-in-covid-19-cases-and-deaths-in-countries-with-insufficient-vaccination-coverage-warns-ecdc/2021-10-01T00:37:46+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-3-9-october-2021-week-40/2021-10-08T14:35:44+02:00https://primarycare.designagency.gr/ecdc-builds-study-infrastructure-to-monitor-covid-19-vaccine-effectiveness/2021-10-08T17:39:38+02:00https://primarycare.designagency.gr/interim-analysis-of-covid-19-vaccine-effectiveness-against-severe-acute-respiratory-infection-due-to-laboratory-confirmed-sars-cov-2-among-individuals-aged-65-years-and-older-ecdc-multi-country-study/2021-10-08T17:39:38+02:00https://primarycare.designagency.gr/core-protocol-for-ecdc-studies-of-covid-19-vaccine-effectiveness-against-hospitalisation-with-severe-acute-respiratory-infection-laboratory-confirmed-with-sars-cov-2-version-1-0/2021-10-08T17:39:38+02:00https://primarycare.designagency.gr/14-day-case-notification-rate-per-100-000-inhabitants-updated-23-september-2021-weeks-38-39/2021-10-14T10:34:44+02:00https://primarycare.designagency.gr/combined-indicator-14-day-notification-rate-testing-rate-and-test-positivity-updated-7-october-2021-weeks-38-39/2021-10-14T10:34:44+02:00https://primarycare.designagency.gr/testing-rates-per-100-000-inhabitants-updated-7-october-2021-week-39/2021-10-14T11:36:33+02:00https://primarycare.designagency.gr/positivity-rates-updated-7-october-2021-week-39/2021-10-14T11:36:34+02:00https://primarycare.designagency.gr/14-day-case-notification-rate-per-100-000-inhabitants-updated-7-october-2021-weeks-38-39/2021-10-14T11:36:34+02:00https://primarycare.designagency.gr/positivity-rates-updated-14-october-2021-week-40/2021-10-14T18:38:57+02:00https://primarycare.designagency.gr/testing-rates-per-100-000-inhabitants-updated-14-october-2021-week-40/2021-10-14T18:38:57+02:00https://primarycare.designagency.gr/14-day-case-notification-rate-per-100-000-inhabitants-updated-14-october-2021-weeks-39-40/2021-10-14T18:38:57+02:00https://primarycare.designagency.gr/combined-indicator-14-day-notification-rate-testing-rate-and-test-positivity-updated-14-october-2021-colour-blind-friendly-weeks-39-40/2021-10-14T18:38:58+02:00https://primarycare.designagency.gr/combined-indicator-14-day-notification-rate-testing-rate-and-test-positivity-updated-14-october-2021-weeks-39-40/2021-10-14T18:38:58+02:00https://primarycare.designagency.gr/infographic-facilitating-covid-19-vaccination-acceptance-and-uptake/2021-10-15T11:37:59+02:00https://primarycare.designagency.gr/ecdc-supports-member-states-to-increase-covid-19-vaccination-acceptance-and-uptake-in-the-eu-eea/2021-10-15T11:37:59+02:00https://primarycare.designagency.gr/facilitating-covid-19-vaccination-acceptance-and-uptake-in-the-eu-eea/2021-10-15T11:37:59+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-10-16-october-2021-week-41/2021-10-15T16:35:38+02:00https://primarycare.designagency.gr/covid-19-surveillance-guidance-transition-from-covid-19-emergency-surveillance-to-routine-surveillance-of-respiratory-pathogens/2021-10-18T12:36:57+02:00https://primarycare.designagency.gr/testing-rates-per-100-000-inhabitants-updated-21-october-2021-week-41/2021-10-21T12:34:44+02:00https://primarycare.designagency.gr/positivity-rates-updated-21-october-2021-week-41/2021-10-21T12:34:44+02:00https://primarycare.designagency.gr/14-day-case-notification-rate-per-100-000-inhabitants-updated-21-october-2021-weeks-40-41/2021-10-21T12:34:44+02:00https://primarycare.designagency.gr/combined-indicator-14-day-notification-rate-testing-rate-and-test-positivity-updated-21-october-2021-colour-blind-friendly-weeks-40-41/2021-10-21T12:34:44+02:00https://primarycare.designagency.gr/combined-indicator-14-day-notification-rate-testing-rate-and-test-positivity-updated-21-october-2021-weeks-40-41/2021-10-21T12:34:44+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-17-23-october-2021-week-42/2021-10-22T14:36:38+02:00https://primarycare.designagency.gr/coronavirus-disease-2019-covid-19-contact-tracing-reporting-protocol-version-1/2021-10-25T18:34:39+02:00https://primarycare.designagency.gr/ecdc-publishes-updated-technical-report-on-options-for-the-use-of-rapid-antigen-detection-tests-for-covid-19-in-the-eu-eea/2021-10-26T14:35:35+02:00https://primarycare.designagency.gr/options-for-the-use-of-rapid-antigen-tests-for-covid-19-in-the-eu-eea-and-the-uk-first-update/2021-10-26T14:35:35+02:00https://primarycare.designagency.gr/options-for-the-use-of-rapid-antigen-tests-for-covid-19-in-the-eu-eea-first-update/2021-10-28T09:36:44+02:00https://primarycare.designagency.gr/positivity-rates-updated-28-october-2021-week-42/2021-10-28T12:41:27+02:00https://primarycare.designagency.gr/testing-rates-per-100-000-inhabitants-updated-28-october-2021-week-42/2021-10-28T12:41:27+02:00https://primarycare.designagency.gr/14-day-case-notification-rate-per-100-000-inhabitants-updated-28-october-2021-weeks-41-42/2021-10-28T12:41:27+02:00https://primarycare.designagency.gr/combined-indicator-14-day-notification-rate-testing-rate-and-test-positivity-updated-28-october-2021-colour-blind-friendly-weeks-41-42/2021-10-28T12:41:27+02:00https://primarycare.designagency.gr/combined-indicator-14-day-notification-rate-testing-rate-and-test-positivity-updated-28-october-2021-weeks-41-42/2021-10-28T12:41:27+02:00https://primarycare.designagency.gr/sources-worldwide-data-on-covid-19/2021-10-28T14:39:00+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-24-30-october-2021-week-43/2021-10-29T16:39:34+02:00https://primarycare.designagency.gr/kefalalgia-kai-pote-apaiteitai-elegchos/2021-11-02T15:10:21+02:00https://primarycare.designagency.gr/14-day-case-notification-rate-per-100-000-inhabitants-updated-4-november-2021-weeks-42-43/2021-11-05T11:41:11+02:00https://primarycare.designagency.gr/combined-indicator-14-day-notification-rate-testing-rate-and-test-positivity-updated-4-november-2021-weeks-42-43/2021-11-05T11:41:11+02:00https://primarycare.designagency.gr/positivity-rates-updated-4-november-2021-week-43/2021-11-05T12:36:16+02:00https://primarycare.designagency.gr/testing-rates-per-100-000-inhabitants-updated-4-november-2021-week-43/2021-11-05T12:36:16+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-31-october-6-november-2021-week-44/2021-11-05T15:36:40+02:00https://primarycare.designagency.gr/new-update-of-the-ecdc-covid-19-vaccine-tracker/2021-11-10T12:34:37+02:00https://primarycare.designagency.gr/combined-indicator-14-day-notification-rate-testing-rate-and-test-positivity-updated-11-november-2021-colour-blind-friendly-weeks-43-44/2021-11-11T13:38:07+02:00https://primarycare.designagency.gr/testing-rates-per-100-000-inhabitants-updated-11-november-2021-week-44/2021-11-11T13:38:07+02:00https://primarycare.designagency.gr/positivity-rates-updated-11-november-2021-week-44/2021-11-11T13:38:07+02:00https://primarycare.designagency.gr/14-day-case-notification-rate-per-100-000-inhabitants-updated-11-november-2021-weeks-43-44/2021-11-11T13:38:08+02:00https://primarycare.designagency.gr/combined-indicator-14-day-notification-rate-testing-rate-and-test-positivity-updated-11-november-2021-weeks-43-44/2021-11-11T13:38:08+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-7-13-november-2021-week-45/2021-11-12T15:38:29+02:00https://primarycare.designagency.gr/14-day-case-notification-rate-per-100-000-inhabitants-updated-18-november-2021-weeks-44-45/2021-11-18T20:37:55+02:00https://primarycare.designagency.gr/testing-rates-per-100-000-inhabitants-updated-18-november-2021-week-45/2021-11-18T20:37:55+02:00https://primarycare.designagency.gr/positivity-rates-updated-18-november-2021-week-45/2021-11-18T20:37:55+02:00https://primarycare.designagency.gr/combined-indicator-14-day-notification-rate-testing-rate-and-test-positivity-updated-18-november-2021-weeks-44-45/2021-11-18T20:37:55+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-14-20-november-2021-week-46/2021-11-19T15:34:54+02:00https://primarycare.designagency.gr/assessment-of-the-current-sars-cov-2-epidemiological-situation-in-the-eu-eea-projections-for-the-end-of-year-festive-season-and-strategies-for-response-17th-update/2021-11-24T12:36:54+02:00https://primarycare.designagency.gr/video-statement-by-dr-andrea-ammon/2021-11-24T12:36:55+02:00https://primarycare.designagency.gr/assessment-of-the-current-sars-cov-2-epidemiological-situation-in-the-eu-eea-projections-for-the-end-of-year-festive-season-and-strategies-for-response-17th-update-2/2021-11-24T13:38:37+02:00https://primarycare.designagency.gr/combined-indicator-14-day-notification-rate-testing-rate-and-test-positivity-updated-25-november-2021-weeks-45-46/2021-11-25T12:37:37+02:00https://primarycare.designagency.gr/combined-indicator-14-day-notification-rate-testing-rate-and-test-positivity-updated-25-november-2021-colour-blind-friendly-weeks-45-46/2021-11-25T12:37:37+02:00https://primarycare.designagency.gr/14-day-case-notification-rate-per-100-000-inhabitants-updated-25-november-2021-weeks-45-46/2021-11-25T12:37:37+02:00https://primarycare.designagency.gr/positivity-rates-updated-25-november-2021-week-46/2021-11-25T12:37:37+02:00https://primarycare.designagency.gr/testing-rates-per-100-000-inhabitants-updated-25-november-2021-week-46/2021-11-25T12:37:37+02:00https://primarycare.designagency.gr/who-ecdc-nearly-half-a-million-lives-saved-by-covid-19-vaccination-in-less-than-a-year/2021-11-25T20:37:25+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-14-20-november-2021-week-47/2021-11-26T15:37:22+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-21-27-november-2021-week-47/2021-11-26T16:38:19+02:00https://primarycare.designagency.gr/ecdc-publishes-threat-assessment-brief-emergence-of-sars-cov-2-variant-b-1-1-529/2021-11-27T00:36:10+02:00https://primarycare.designagency.gr/threat-assessment-brief-implications-of-the-emergence-and-spread-of-the-sars-cov-2-b-1-1-529-variant-of-concern-omicron-for-the-eu-eea/2021-11-27T00:36:10+02:00https://primarycare.designagency.gr/epidemiological-update-omicron-variant-of-concern-voc-data-as-of-29-november-2021-1230/2021-11-29T16:35:57+02:00https://primarycare.designagency.gr/surveillance-of-covid-19-in-long-term-care-facilities-in-the-eu-eea/2021-11-29T16:35:57+02:00https://primarycare.designagency.gr/epidemiological-update-omicron-variant-of-concern-voc-data-as-of-30-november-2021-12-00/2021-11-30T15:38:11+02:00https://primarycare.designagency.gr/epidemiological-update-omicron-variant-of-concern-voc-data-as-of-1-december-2021-12-00/2021-12-01T14:36:53+02:00https://primarycare.designagency.gr/considerations-for-vaccinating-children-5-11-years-old/2021-12-01T17:35:07+02:00https://primarycare.designagency.gr/interim-public-health-considerations-for-covid-19-vaccination-of-children-aged-5-11-years/2021-12-01T17:35:08+02:00https://primarycare.designagency.gr/threat-assessment-brief-implications-of-the-further-emergence-and-spread-of-the-sars-cov-2-b-1-1-529-variant-of-concern-omicron-for-the-eu-eea-first-update/2021-12-02T14:35:17+02:00https://primarycare.designagency.gr/epidemiological-update-omicron-variant-of-concern-voc-data-as-of-2-december-2021-12-00/2021-12-02T15:34:37+02:00https://primarycare.designagency.gr/today-ecdc-released-an-updated-threat-assessment-brief-on-the-sars-cov-2-variant-b-1-1-529-known-as-omicron/2021-12-02T15:34:37+02:00https://primarycare.designagency.gr/positivity-rates-updated-2-december-2021/2021-12-02T16:37:23+02:00https://primarycare.designagency.gr/testing-rates-per-100-000-inhabitants-updated-2-december-2021/2021-12-02T16:37:24+02:00https://primarycare.designagency.gr/14-day-case-notification-rate-per-100-000-inhabitants-updated-2-december-2021/2021-12-02T16:37:24+02:00https://primarycare.designagency.gr/combined-indicator-14-day-notification-rate-testing-rate-and-test-positivity-updated-2-december-2021-colour-blind-friendly/2021-12-02T16:37:24+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-28-november-4-december-2021-week-48/2021-12-03T15:34:36+02:00https://primarycare.designagency.gr/epidemiological-update-omicron-variant-of-concern-voc-data-as-of-3-december-2021-12-00/2021-12-03T17:34:41+02:00https://primarycare.designagency.gr/epidemiological-update-omicron-variant-of-concern-voc-data-as-of-4-december-2021-12-00/2021-12-04T15:35:48+02:00https://primarycare.designagency.gr/epidemiological-update-omicron-variant-of-concern-voc-data-as-of-5-december-2021-12-00/2021-12-05T15:34:46+02:00https://primarycare.designagency.gr/epidemiological-update-omicron-variant-of-concern-voc-data-as-of-6-december-2021-12-00/2021-12-06T15:34:37+02:00https://primarycare.designagency.gr/webinar-on-post-covid-19-condition-in-children/2021-12-07T13:34:39+02:00https://primarycare.designagency.gr/ema-and-ecdc-recommendations-on-heterologous-vaccination-courses-against-covid-19/2021-12-07T13:34:39+02:00https://primarycare.designagency.gr/epidemiological-update-omicron-variant-of-concern-voc-data-as-of-7-december-2021-12-00/2021-12-07T17:38:16+02:00https://primarycare.designagency.gr/webinar-on-post-covid-19-condition-in-children-2/2021-12-08T10:42:20+02:00https://primarycare.designagency.gr/epidemiological-update-omicron-variant-of-concern-voc-data-as-of-8-december-2021-12-00/2021-12-08T16:36:30+02:00https://primarycare.designagency.gr/combined-indicator-14-day-notification-rate-testing-rate-and-test-positivity-updated-2-december-2021-colour-blind-friendly-weeks-47-48/2021-12-09T13:35:21+02:00https://primarycare.designagency.gr/testing-rates-per-100-000-inhabitants-updated-9-december-2021-week-48/2021-12-09T13:35:21+02:00https://primarycare.designagency.gr/14-day-case-notification-rate-per-100-000-inhabitants-updated-9-december-2021-weeks-47-48/2021-12-09T13:35:22+02:00https://primarycare.designagency.gr/positivity-rates-updated-9-december-2021-week-48/2021-12-09T13:35:22+02:00https://primarycare.designagency.gr/epidemiological-update-omicron-variant-of-concern-voc-data-as-of-9-december-2021-1200/2021-12-09T17:37:37+02:00https://primarycare.designagency.gr/timely-actions-are-needed-to-rapidly-detect-and-control-outbreaks-in-long-term-care-facilities/2021-12-09T18:39:08+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-5-11-december-2021-week-49/2021-12-10T16:36:21+02:00https://primarycare.designagency.gr/epidemiological-update-omicron-variant-of-concern-voc-data-as-of-10-december-2021-1200/2021-12-10T18:37:11+02:00https://primarycare.designagency.gr/epidemiological-update-omicron-variant-of-concern-voc-data-as-of-11-december-2021-1200/2021-12-11T15:36:18+02:00https://primarycare.designagency.gr/epidemiological-update-omicron-variant-of-concern-voc-data-as-of-12-december-2021-1200/2021-12-12T15:37:17+02:00https://primarycare.designagency.gr/epidemiological-update-omicron-variant-of-concern-voc-data-as-of-13-december-2021-1200/2021-12-13T15:36:28+02:00https://primarycare.designagency.gr/generic-protocol-for-covid-19-vaccine-effectiveness-studies-during-outbreaks-in-semi-closed-settings-in-the-eu-eea/2021-12-14T12:41:47+02:00https://primarycare.designagency.gr/epidemiological-update-omicron-variant-of-concern-voc-data-as-of-14-december-2021-1200/2021-12-14T15:34:49+02:00https://primarycare.designagency.gr/video-ecdc-message-on-the-covid-19-situation-holidays-2021/2021-12-15T16:35:22+02:00https://primarycare.designagency.gr/ecdc-publishes-new-risk-assessment-on-further-emergence-of-omicron-variant/2021-12-15T16:35:22+02:00https://primarycare.designagency.gr/assessment-of-the-further-emergence-of-the-sars-cov-2-omicron-voc-in-the-context-of-the-ongoing-delta-voc-transmission-in-the-eu-eea-18th-update/2021-12-15T16:35:22+02:00https://primarycare.designagency.gr/epidemiological-update-omicron-variant-of-concern-voc-data-as-of-15-december-2021-1200/2021-12-15T17:39:38+02:00https://primarycare.designagency.gr/epidemiological-update-omicron-variant-of-concern-voc-data-as-of-16-december-2021-1200/2021-12-16T16:40:04+02:00https://primarycare.designagency.gr/14-day-case-notification-rate-per-100-000-inhabitants-updated-16-december-2021-weeks-48-49/2021-12-16T17:35:20+02:00https://primarycare.designagency.gr/testing-rates-per-100-000-inhabitants-updated-16-december-2021-week-49/2021-12-16T17:35:20+02:00https://primarycare.designagency.gr/positivity-rates-updated-16-december-2021-week-49/2021-12-16T17:35:20+02:00https://primarycare.designagency.gr/combined-indicator-14-day-notification-rate-testing-rate-and-test-positivity-updated-16-december-2021-weeks-48-49/2021-12-16T17:35:20+02:00https://primarycare.designagency.gr/communicable-diseases-threat-report-12-18-december-2021-week-50/2021-12-17T17:34:41+02:00https://primarycare.designagency.gr/weekly-epidemiological-update-omicron-variant-of-concern-voc-week-50-data-as-of-19-december-2021/2021-12-20T11:38:37+02:00https://primarycare.designagency.gr/methods-for-the-detection-and-characterisation-of-sars-cov-2-variants-first-update/2021-12-20T11:38:37+02:00https://primarycare.designagency.gr/rapid-assessment-of-antigenic-characterisation-capability-and-capacity-for-sars-cov-2-viruses-in-eu-eea-laboratories/2021-12-20T12:36:04+02:00https://primarycare.designagency.gr/communicable-diseases-threats-report-12-18-december-2021-week-50/2021-12-20T14:36:00+02:00https://primarycare.designagency.gr/positivity-rates-updated-23-december-2021/2021-12-23T12:34:51+02:00https://primarycare.designagency.gr/testing-rates-per-100-000-inhabitants-updated-23-december-2021/2021-12-23T12:34:51+02:00https://primarycare.designagency.gr/indicator-14-day-notification-rate-testing-rate-and-test-positivity-14-day-case-notification-rate-per-100-000-inhabitants-updated-23-december-2021/2021-12-23T12:34:51+02:00https://primarycare.designagency.gr/combined-indicator-14-day-notification-rate-testing-rate-and-test-positivity-updated-23-december-2021-colour-blind-friendly/2021-12-23T12:34:51+02:00https://primarycare.designagency.gr/combined-indicator-14-day-notification-rate-testing-rate-and-test-positivity-updated-23-december-2021/2021-12-23T12:34:51+02:00https://primarycare.designagency.gr/testing-rates-per-100-000-inhabitants-updated-30-december-2021/2021-12-30T11:36:34+02:00https://primarycare.designagency.gr/14-day-case-notification-rate-per-100-000-inhabitants-updated-30-december-2021/2021-12-30T11:36:34+02:00https://primarycare.designagency.gr/combined-indicator-14-day-notification-rate-testing-rate-and-test-positivity-updated-30-december-2021/2021-12-30T11:36:34+02:00https://primarycare.designagency.gr/combined-indicator-14-day-notification-rate-testing-rate-and-test-positivity-updated-30-december-2021-colour-blind-friendly/2021-12-30T11:36:34+02:00https://primarycare.designagency.gr/positivity-rates-updated-30-december-2021/2021-12-30T11:36:35+02:00https://primarycare.designagency.gr/this-winters-flu-season-epidemic-has-started-what-we-know-so-far-and-what-needs-to-be-done-to-control-it/2022-01-02T11:39:59+02:00https://primarycare.designagency.gr/testing-rates-per-100-000-inhabitants-updated-6-january-2022/2022-01-06T17:41:51+02:00https://primarycare.designagency.gr/14-day-case-notification-rate-per-100-000-inhabitants-updated-6-january-2022/2022-01-06T17:41:51+02:00https://primarycare.designagency.gr/combined-indicator-14-day-notification-rate-testing-rate-and-test-positivity-updated-6-january-2022-colour-blind-friendly/2022-01-06T17:41:51+02:00https://primarycare.designagency.gr/positivity-rates-updated-6-january-2022/2022-01-06T17:41:51+02:00https://primarycare.designagency.gr/combined-indicator-14-day-notification-rate-testing-rate-and-test-positivity-updated-6-january-2021/2022-01-06T17:41:51+02:00https://primarycare.designagency.gr/communicable-diseases-threats-report-2-8-january-2022-week-1/2022-01-07T19:37:55+02:00https://primarycare.designagency.gr/weekly-epidemiological-update-omicron-variant-of-concern-voc-week-1-data-as-of-7-january-2022-eu-eea/2022-01-07T19:37:55+02:00https://primarycare.designagency.gr/ecdc-updates-its-guidance-regarding-quarantine-and-isolation-considering-the-rapid-spread-of-omicron-in-the-eu-eea/2022-01-07T23:34:34+02:00https://primarycare.designagency.gr/invitation-to-digital-press-briefing-with-the-eu-commissioner-for-health-and-food-safety-the-swedish-minister-for-health-and-social-affairs-and-the-ecdc-director/2022-01-10T08:38:57+02:00https://primarycare.designagency.gr/positivity-rates-updated-13-january-2022/2022-01-13T15:41:29+02:00https://primarycare.designagency.gr/testing-rates-per-100-000-inhabitants-updated-13-january-2022/2022-01-13T15:41:29+02:00https://primarycare.designagency.gr/14-day-case-notification-rate-per-100-000-inhabitants-updated-13-january-2022/2022-01-13T15:41:29+02:00https://primarycare.designagency.gr/combined-indicator-14-day-notification-rate-testing-rate-and-test-positivity-updated-13-january-2022-weeks-52-01/2022-01-13T15:41:29+02:00https://primarycare.designagency.gr/weekly-epidemiological-update-omicron-variant-of-concern-voc-week-2-data-as-of-13-january-2022-eu-eea/2022-01-14T10:38:35+02:00https://primarycare.designagency.gr/communicable-diseases-threats-report-9-15-january-2022-week-2/2022-01-14T15:36:35+02:00https://primarycare.designagency.gr/positivity-rates-updated-20-january-2022/2022-01-20T12:42:11+02:00https://primarycare.designagency.gr/testing-rates-per-100-000-inhabitants-updated-20-january-2022/2022-01-20T12:42:11+02:00https://primarycare.designagency.gr/14-day-case-notification-rate-per-100-000-inhabitants-updated-20-january-2022/2022-01-20T12:42:11+02:00https://primarycare.designagency.gr/10o-panellinio-synedrio-ellinikoy-kolegioy-genikis-iatrikis/2022-01-20T13:22:20+02:00https://primarycare.designagency.gr/weekly-epidemiological-update-omicron-variant-of-concern-voc-week-2-data-as-of-20-january-2022-eu-eea/2022-01-21T12:37:04+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-16-22-january-2022-week-3/2022-01-21T15:35:44+02:00https://primarycare.designagency.gr/strenghtening-covid-19-information-and-vaccination-caravans-in-rural-communities-from-romania/2022-01-27T13:36:34+02:00https://primarycare.designagency.gr/14-day-case-notification-rate-per-100-000-inhabitants-updated-27-january-2022/2022-01-27T14:35:32+02:00https://primarycare.designagency.gr/combined-indicator-14-day-notification-rate-testing-rate-and-test-positivity-updated-27-january-2022-colour-blind-friendly/2022-01-27T14:35:32+02:00https://primarycare.designagency.gr/combined-indicator-14-day-notification-rate-testing-rate-and-test-positivity-updated-27-january-2022/2022-01-27T14:35:32+02:00https://primarycare.designagency.gr/societal-pressure-from-unprecedented-omicron-spread-can-be-eased-through-increased-vaccination-uptake/2022-01-27T14:35:32+02:00https://primarycare.designagency.gr/strengthening-covid-19-information-and-vaccination-caravans-in-rural-communities-from-romania/2022-01-27T14:35:32+02:00https://primarycare.designagency.gr/assessment-of-the-further-emergence-and-potential-impact-of-the-sars-cov-2-omicron-variant-of-concern-in-the-eu-eea-19th-update/2022-01-27T14:35:32+02:00https://primarycare.designagency.gr/guidance-on-ending-the-isolation-period-for-people-with-covid-19-third-update/2022-01-28T13:41:22+02:00https://primarycare.designagency.gr/video-ecdc-update-on-omicron-in-the-eu-eea/2022-01-28T14:36:59+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-23-29-january-2022-week-4/2022-01-28T15:35:58+02:00https://primarycare.designagency.gr/14-day-notification-rate-weighted-by-vaccine-uptake-updated-1-february-2022-colour-blind-friendly/2022-02-01T16:37:06+02:00https://primarycare.designagency.gr/14-day-notification-rate-weighted-by-vaccine-uptake-updated-1-february-2022/2022-02-01T16:37:06+02:00https://primarycare.designagency.gr/14-day-notification-rate-weighted-by-vaccine-uptake-updated-3-february-2022-colour-blind-friendly/2022-02-03T13:35:25+02:00https://primarycare.designagency.gr/14-day-notification-rate-weighted-by-vaccine-uptake-updated-3-february-2022-colour-blind-friendly-2/2022-02-03T13:35:25+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-30-january-5-february-2022-week-5/2022-02-04T15:37:12+02:00https://primarycare.designagency.gr/e-learning-understanding-vaccine-acceptance-strategies-to-increase-vaccine-uptake/2022-02-07T14:37:05+02:00https://primarycare.designagency.gr/ecdc-publishes-updated-considerations-for-use-of-face-masks-in-the-community/2022-02-07T17:34:35+02:00https://primarycare.designagency.gr/considerations-for-the-use-of-face-masks-in-the-community-in-the-context-of-the-sars-cov-2-omicron-variant-of-concern/2022-02-07T17:34:35+02:00https://primarycare.designagency.gr/covid-19-vaccines-for-adolescents-offer-a-very-high-level-of-protection-against-infection-symptomatic-disease-and-severe-disease/2022-02-08T15:34:33+02:00https://primarycare.designagency.gr/covid-19-vaccine-effectiveness-in-adolescents-aged-12-17-years-and-interim-public-health-considerations-for-administration-of-a-booster-dose/2022-02-08T15:34:33+02:00https://primarycare.designagency.gr/14-day-notification-rate-weighted-by-vaccine-uptake-updated-10-february-2022-colour-blind-friendly/2022-02-10T12:34:45+02:00https://primarycare.designagency.gr/14-day-notification-rate-weighted-by-vaccine-uptake-updated-10-february-2022/2022-02-10T12:34:45+02:00https://primarycare.designagency.gr/considerations-for-the-use-of-antibody-tests-for-sars-cov-2-first-update/2022-02-10T16:37:07+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-6-12-february-2022-week-6/2022-02-11T15:37:09+02:00https://primarycare.designagency.gr/evaluation-of-the-sars-cov-2-testing-policy-in-belgium-from-june-to-december-2021/2022-02-14T15:37:10+02:00https://primarycare.designagency.gr/14-day-notification-rate-weighted-by-vaccine-uptake-updated-17-february-2022-colour-blind-friendly/2022-02-17T16:37:24+02:00https://primarycare.designagency.gr/14-day-notification-rate-weighted-by-vaccine-uptake-updated-17-february-2022/2022-02-17T16:37:24+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-13-19-february-2022-week-7/2022-02-18T17:34:55+02:00https://primarycare.designagency.gr/multisystem-inflammatory-syndrome-in-children-mis-c/2022-02-22T11:34:49+02:00https://primarycare.designagency.gr/14-day-notification-rate-weighted-by-vaccine-uptake-updated-24-february-2022-colour-blind-friendly/2022-02-24T16:37:05+02:00https://primarycare.designagency.gr/14-day-notification-rate-weighted-by-vaccine-uptake-updated-24-february-2022/2022-02-24T16:37:06+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-20-26-february-2022-week-8/2022-02-25T17:37:21+02:00https://primarycare.designagency.gr/14-day-notification-rate-weighted-by-vaccine-uptake-updated-3-march-2022-colour-blind-friendly/2022-03-03T18:37:08+02:00https://primarycare.designagency.gr/14-day-notification-rate-weighted-by-vaccine-uptake-updated-3-march-2022/2022-03-03T18:37:08+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-27-february-5-march-2022-week-9/2022-03-04T15:37:20+02:00https://primarycare.designagency.gr/14-day-notification-rate-weighted-by-vaccine-uptake-updated-3-march-2022-colour-blind-friendly-2/2022-03-10T12:35:12+02:00https://primarycare.designagency.gr/14-day-notification-rate-weighted-by-vaccine-uptake-updated-10-march-2022/2022-03-10T12:35:12+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-6-11-march-2022-week-10/2022-03-11T15:37:07+02:00https://primarycare.designagency.gr/analysis-of-covid-19-contact-tracing-data-from-ireland-italy-and-spain-2020-data/2022-03-15T11:37:22+02:00https://primarycare.designagency.gr/14-day-notification-rate-weighted-by-vaccine-uptake-updated-17-march-2022-colour-blind-friendly/2022-03-17T15:37:09+02:00https://primarycare.designagency.gr/14-day-notification-rate-weighted-by-vaccine-uptake-updated-17-march-2022/2022-03-17T15:37:09+02:00https://primarycare.designagency.gr/14-day-notification-rate-weighted-by-vaccine-uptake-updated-10-march-2022-colour-blind-friendly/2022-03-17T15:37:10+02:00https://primarycare.designagency.gr/covid-19-testing-vaccination-and-implementation-of-protective-measures-recommended-for-reception-centres-of-displaced-people-from-ukraine/2022-03-18T15:37:14+02:00https://primarycare.designagency.gr/guidance-for-the-prevention-and-control-of-covid-19-in-temporary-reception-centres-in-the-context-of-the-large-numbers-of-people-fleeing-ukraine/2022-03-18T15:37:15+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-13-19-march-2022-week-11/2022-03-18T16:37:21+02:00https://primarycare.designagency.gr/14-day-notification-rate-weighted-by-vaccine-uptake-updated-24-march-2022-colour-blind-friendly/2022-03-24T13:37:08+02:00https://primarycare.designagency.gr/14-day-notification-rate-weighted-by-vaccine-uptake-updated-24-march-2022/2022-03-24T13:37:08+02:00https://primarycare.designagency.gr/14-day-notification-rate-weighted-by-vaccine-uptake-updated-17-march-2022-2/2022-03-24T13:37:08+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-20-26-march-2022-week-12/2022-03-25T15:36:57+02:00https://primarycare.designagency.gr/infographic-considerations-for-the-provision-of-immunisation-services-to-people-fleeing-ukraine-and-the-prevention-of-vaccine-preventable-disease-outbreaks/2022-03-30T15:37:26+02:00https://primarycare.designagency.gr/14-day-notification-rate-weighted-by-vaccine-uptake-updated-31-march-2022-colour-blind-friendly/2022-03-31T11:34:49+02:00https://primarycare.designagency.gr/14-day-notification-rate-weighted-by-vaccine-uptake-updated-31-march-2022/2022-03-31T11:34:49+02:00https://primarycare.designagency.gr/14-day-notification-rate-weighted-by-vaccine-uptake-updated-31-march-2022-2/2022-03-31T12:37:16+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-27-march-2-april-2022-week-13/2022-04-01T14:35:21+02:00https://primarycare.designagency.gr/covid-19-joint-statement-from-ecdc-and-ema-on-the-administration-of-a-fourth-dose-of-mrna-vaccines/2022-04-06T16:36:23+02:00https://primarycare.designagency.gr/video-ecdc-director-on-fourth-doses-of-mrna-covid-19-vaccines/2022-04-06T17:35:36+02:00https://primarycare.designagency.gr/ecdc-and-ema-issue-advice-on-fourth-doses-of-mrna-covid-19-vaccines/2022-04-06T17:35:36+02:00https://primarycare.designagency.gr/14-day-notification-rate-weighted-by-vaccine-uptake-updated-7-april-2022-colour-blind-friendly/2022-04-07T18:37:09+02:00https://primarycare.designagency.gr/14-day-notification-rate-weighted-by-vaccine-uptake-updated-7-april-2022/2022-04-07T18:37:09+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-3-9-april-2022-week-14/2022-04-08T15:37:10+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-10-16-april-2022-week-15/2022-04-13T16:35:44+02:00https://primarycare.designagency.gr/14-day-notification-rate-weighted-by-vaccine-uptake-updated-14-april-2022-colour-blind-friendly/2022-04-14T13:35:02+02:00https://primarycare.designagency.gr/14-day-notification-rate-weighted-by-vaccine-uptake-updated-14-april-2022/2022-04-14T13:35:02+02:00https://primarycare.designagency.gr/kalo-pascha/2022-04-20T15:23:36+02:00https://primarycare.designagency.gr/14-day-notification-rate-weighted-by-vaccine-uptake-updated-21-april-2022-colour-blind-friendly/2022-04-21T11:37:16+02:00https://primarycare.designagency.gr/14-day-notification-rate-weighted-by-vaccine-uptake-updated-21-april-2022/2022-04-21T11:37:16+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-17-23-april-2022-week-16/2022-04-22T17:35:33+02:00https://primarycare.designagency.gr/european-immunization-week-2022/2022-04-25T15:36:48+02:00https://primarycare.designagency.gr/social-media-card-covid-19-in-children/2022-04-26T10:37:07+02:00https://primarycare.designagency.gr/social-media-card-900-million-covid-19-vaccine-doses-administered/2022-04-26T10:37:07+02:00https://primarycare.designagency.gr/social-media-card-covid-19-in-adolescents/2022-04-26T10:37:07+02:00https://primarycare.designagency.gr/social-media-card-covid-19-vaccination/2022-04-26T10:37:07+02:00https://primarycare.designagency.gr/transitioning-beyond-the-acute-phase-of-the-covid-19-pandemic-approaches-and-tools-used-by-a-sample-of-eu-countries-in-the-transition-and-de-escalation-phase-interim-report/2022-04-27T16:36:59+02:00https://primarycare.designagency.gr/14-day-notification-rate-weighted-by-vaccine-uptake-updated-28-april-2022-colour-blind-friendly/2022-04-28T10:37:21+02:00https://primarycare.designagency.gr/14-day-notification-rate-weighted-by-vaccine-uptake-updated-28-april-2022/2022-04-28T10:37:21+02:00https://primarycare.designagency.gr/video-why-were-covid-19-mrna-vaccines-developed-so-fast/2022-04-28T11:37:10+02:00https://primarycare.designagency.gr/video-how-do-covid-19-mrna-vaccines-work/2022-04-28T11:37:10+02:00https://primarycare.designagency.gr/a-second-booster-could-avert-a-substantial-proportion-of-covid-19-deaths-between-now-and-mid-autumn-2022-in-older-age-groups/2022-04-28T16:36:03+02:00https://primarycare.designagency.gr/public-health-considerations-and-evidence-to-support-decisions-on-the-implementation-of-a-second-mrna-covid-19-vaccine-booster-dose/2022-04-28T16:36:03+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-24-30-april-2022-week-17/2022-04-29T15:34:45+02:00https://primarycare.designagency.gr/14-day-notification-rate-weighted-by-vaccine-uptake-updated-28-april-2022-2/2022-05-05T10:36:20+02:00https://primarycare.designagency.gr/14-day-notification-rate-weighted-by-vaccine-uptake-updated-5-may-2022-colour-blind-friendly/2022-05-05T12:35:18+02:00https://primarycare.designagency.gr/14-day-notification-rate-weighted-by-vaccine-uptake-updated-5-may-2022/2022-05-05T12:35:19+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-1-7-may-2022-week-18/2022-05-06T15:35:48+02:00https://primarycare.designagency.gr/easa-and-ecdc-take-first-steps-to-relax-covid-19-measures-for-air-travel/2022-05-11T10:37:11+02:00https://primarycare.designagency.gr/14-day-notification-rate-weighted-by-vaccine-uptake-updated-12-may-2022-colour-blind-friendly/2022-05-12T11:36:43+02:00https://primarycare.designagency.gr/14-day-notification-rate-weighted-by-vaccine-uptake-updated-12-may-2022/2022-05-12T11:36:43+02:00https://primarycare.designagency.gr/epidemiological-update-on-sars-cov-2-omicron-sub-lineages-ba-4-and-ba-5/2022-05-13T15:37:18+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-8-14-may-2022-week-19/2022-05-13T16:37:20+02:00https://primarycare.designagency.gr/14-day-notification-rate-weighted-by-vaccine-uptake-updated-19-may-2022/2022-05-19T11:34:55+02:00https://primarycare.designagency.gr/14-day-notification-rate-weighted-by-vaccine-uptake-updated-19-may-2022-colour-blind-friendly/2022-05-19T12:35:35+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-15-21-may-2022-week-20/2022-05-20T16:37:13+02:00https://primarycare.designagency.gr/14-day-notification-rate-weighted-by-vaccine-uptake-updated-26-may-2022-colour-blind-friendly/2022-05-26T12:34:52+02:00https://primarycare.designagency.gr/14-day-notification-rate-weighted-by-vaccine-uptake-updated-26-may-2022/2022-05-26T12:34:52+02:00https://primarycare.designagency.gr/launch-of-scenario-hub-projecting-future-covid-19-health-impact/2022-05-30T15:37:10+02:00https://primarycare.designagency.gr/14-day-notification-rate-weighted-by-vaccine-uptake-updated-2-june-2022-colour-blind-friendly/2022-06-02T14:34:37+02:00https://primarycare.designagency.gr/14-day-notification-rate-weighted-by-vaccine-uptake-updated-2-june-2022/2022-06-02T14:34:37+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-29-4-june-2022-week-22/2022-06-03T17:35:51+02:00https://primarycare.designagency.gr/technical-guidance-for-antigenic-sars-cov-2-monitoring/2022-06-07T14:34:47+02:00https://primarycare.designagency.gr/ecdc-issues-guidance-on-scaling-up-capability-and-capacity-to-characterise-sars-cov-2-variants/2022-06-08T14:34:38+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-29-may-4-june-2022-week-22/2022-06-08T16:34:42+02:00https://primarycare.designagency.gr/14-day-notification-rate-weighted-by-vaccine-uptake-updated-9-june-2022-colour-blind-friendly/2022-06-09T14:37:21+02:00https://primarycare.designagency.gr/14-day-notification-rate-weighted-by-vaccine-uptake-updated-9-june-2022/2022-06-09T14:37:21+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-5-11-june-2022-week-23/2022-06-10T15:35:43+02:00https://primarycare.designagency.gr/implications-of-the-emergence-and-spread-of-the-sars-cov-2-variants-of-concern-ba-4-and-ba-5-for-the-eu-eea/2022-06-13T13:35:23+02:00https://primarycare.designagency.gr/14-day-notification-rate-weighted-by-vaccine-uptake-updated-9-june-2022-colour-blind-friendly-2/2022-06-16T14:36:21+02:00https://primarycare.designagency.gr/14-day-notification-rate-weighted-by-vaccine-uptake-updated-16-june-2022/2022-06-16T14:36:22+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-12-18-june-2022-week-24/2022-06-17T14:37:46+02:00https://primarycare.designagency.gr/survey-on-the-implementation-of-integrated-surveillance-of-respiratory-viruses-with-pandemic-potential/2022-06-17T16:37:18+02:00https://primarycare.designagency.gr/14-day-notification-rate-weighted-by-vaccine-uptake-updated-23-june-2022-colour-blind-friendly/2022-06-23T12:37:22+02:00https://primarycare.designagency.gr/14-day-notification-rate-weighted-by-vaccine-uptake-updated-23-june-2022/2022-06-23T12:37:22+02:00https://primarycare.designagency.gr/download-historical-data-to-20-june-2022-on-the-weekly-number-of-new-reported-covid-19-cases-and-deaths-worldwide/2022-06-23T12:37:22+02:00https://primarycare.designagency.gr/14-day-notification-rate-weighted-by-vaccine-uptake-updated-30-june-2022-colour-blind-friendly/2022-06-30T10:36:12+02:00https://primarycare.designagency.gr/14-day-notification-rate-weighted-by-vaccine-uptake-updated-30-june-2022/2022-06-30T10:36:12+02:00https://primarycare.designagency.gr/weekly-covid-19-country-overview/2022-07-01T11:37:07+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-26-june-2-july-2022-week-26/2022-07-01T16:37:22+02:00https://primarycare.designagency.gr/joint-ecdc-who-europe-covid-19-surveillance-bulletin/2022-07-01T17:37:08+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-3-9-july-2022-week-27/2022-07-08T14:37:13+02:00https://primarycare.designagency.gr/ecdc-and-ema-update-recommendations-on-additional-booster-doses-of-covid-19-vaccines/2022-07-11T11:35:38+02:00https://primarycare.designagency.gr/updated-joint-statement-from-ecdc-and-ema-on-additional-booster-doses-of-covid-19-vaccines/2022-07-11T11:35:38+02:00https://primarycare.designagency.gr/covid-19-contact-tracing-country-experiences-and-way-forward/2022-07-12T12:36:29+02:00https://primarycare.designagency.gr/14-day-notification-rate-weighted-by-vaccine-uptake-updated-14-july-2022-colour-blind-friendly/2022-07-15T12:37:07+02:00https://primarycare.designagency.gr/14-day-notification-rate-weighted-by-vaccine-uptake-updated-14-july-2022/2022-07-15T12:37:07+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-10-16-july-week-28/2022-07-15T15:35:26+02:00https://primarycare.designagency.gr/ecdc-releases-publications-on-covid-19-vaccination-strategies-and-joint-ecdc-who-report-on-considerations-for-respiratory-diseases-as-guidance-for-the-second-half-of-the-year/2022-07-18T13:35:03+02:00https://primarycare.designagency.gr/preliminary-public-health-considerations-for-covid-19-vaccination-strategies-in-the-second-half-of-2022/2022-07-18T13:35:03+02:00https://primarycare.designagency.gr/operational-considerations-for-respiratory-virus-surveillance-in-europe/2022-07-18T13:35:04+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-17-23-july-week-29/2022-07-22T16:37:20+02:00https://primarycare.designagency.gr/ecdc-expert-consultation-on-knowledge-and-research-gaps-related-to-the-covid-19-public-health-response/2022-07-29T16:37:19+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-24-30-july-week-30/2022-07-29T17:37:15+02:00https://primarycare.designagency.gr/methods-for-the-detection-and-characterisation-of-sars-cov-2-variants-second-update/2022-08-02T10:35:01+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-31-july-6-august-week-31/2022-08-05T16:34:39+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-7-13-august-2022-week-32/2022-08-12T16:35:20+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-14-20-august-2022-week-33/2022-08-19T15:37:15+02:00https://primarycare.designagency.gr/generic-protocol-for-covid-19-vaccine-effectiveness-studies-at-long-term-care-facilities-in-the-eu-eea/2022-08-24T10:36:57+02:00https://primarycare.designagency.gr/covid-19-and-other-respiratory-viruses-mitigating-their-spread-as-children-return-to-school-across-europe/2022-08-25T11:37:16+02:00https://primarycare.designagency.gr/long-term-qualitative-scenarios-and-considerations-of-their-implications-for-preparedness-and-response-to-the-covid-19-pandemic-in-the-eu-eea/2022-08-29T10:36:56+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-28-august-3-september-2022-week-35/2022-09-02T16:35:40+02:00https://primarycare.designagency.gr/covid-19-recommendations-on-use-of-adapted-vaccines/2022-09-06T15:37:19+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-4-10-september-2022-week-36/2022-09-09T15:35:33+02:00https://primarycare.designagency.gr/evidence-based-decision-making-after-action-review-on-long-term-care-facilities-in-georgia/2022-09-09T17:37:12+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-11-17-september-2022-week-37/2022-09-16T17:35:40+02:00https://primarycare.designagency.gr/pilot-protocol-for-a-covid-19-vaccine-effectiveness-study-using-health-data-registries/2022-09-19T10:37:16+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-18-24-september-2022-week-38/2022-09-23T16:35:08+02:00https://primarycare.designagency.gr/the-eu-experience-in-the-first-phase-of-covid-19-implications-for-measuring-preparedness/2022-09-26T10:37:26+02:00https://primarycare.designagency.gr/social-contact-patterns-in-the-eu-eea-during-the-covid-19-pandemic/2022-09-27T09:34:49+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-25-september-1-october-2022-week-39/2022-09-30T16:37:12+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-2-8-october-2022-week-40/2022-10-07T21:36:02+02:00https://primarycare.designagency.gr/response-measures-database-rmd/2022-10-13T10:37:14+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-9-15-october-2022-week-41/2022-10-17T08:37:18+02:00https://primarycare.designagency.gr/17o-panellinio-polythematiko-synedrio/2022-10-17T21:50:08+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-16-22-october-2022-week-42/2022-10-21T17:37:11+02:00https://primarycare.designagency.gr/new-omicron-sub-lineage-likely-to-cause-further-increase-in-covid-19-cases/2022-10-21T17:37:11+02:00https://primarycare.designagency.gr/laboratory-support-for-sars-cov-2-virus-neutralisation-in-the-eu-eea-a-pilot-study/2022-10-24T13:21:17+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-23-29-october-2022-week-43/2022-10-28T16:34:51+02:00https://primarycare.designagency.gr/prevalence-of-post-covid-19-condition-symptoms-a-systematic-review-and-meta-analysis-of-cohort-study-data-stratified-by-recruitment-setting/2022-10-31T13:47:19+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-30-october-5-november-2022-week-44/2022-11-04T16:37:24+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-6-12-november-2022/2022-11-11T19:36:37+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-6-12-november-2022-week-45/2022-11-11T20:35:49+02:00https://primarycare.designagency.gr/generic-protocol-for-ecdc-studies-of-covid-19-vaccine-effectiveness-against-confirmed-sars-cov-2-using-healthcare-worker-cohorts-version-2-0/2022-11-21T11:37:20+02:00https://primarycare.designagency.gr/interim-analysis-of-covid-19-vaccine-effectiveness-in-healthcare-workers-an-ecdc-multi-country-study-may-2021-july-2022/2022-11-21T11:37:20+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-20-26-november-2022-week-47/2022-11-26T07:49:04+02:00https://primarycare.designagency.gr/joint-ec-who-and-ecdc-statement-influenza-season-epidemic-kicks-off-early-in-europe-as-concerns-over-rsv-rise-and-covid-19-is-still-a-threat/2022-12-01T13:35:11+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-27-november-3-december-2022-week-48/2022-12-02T18:45:04+02:00https://primarycare.designagency.gr/8th-joint-ecdc-who-europe-annual-european-influenza-and-covid-19-surveillance-meeting/2022-12-05T14:36:31+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-4-10-december-2022-week-49/2022-12-09T16:34:56+02:00https://primarycare.designagency.gr/intensified-circulation-of-respiratory-syncytial-virus-rsv-and-associated-hospital-burden-in-the-eu-eea/2022-12-12T19:35:39+02:00https://primarycare.designagency.gr/risk-of-severe-pressure-on-healthcare-systems-due-to-rsv-flu-and-covid-19-co-circulation/2022-12-12T19:35:40+02:00https://primarycare.designagency.gr/ecdc-expert-consultation-on-the-implementation-and-evaluation-of-non-pharmaceutical-interventions/2022-12-14T13:37:19+02:00https://primarycare.designagency.gr/coronavirus-disease-2019-covid-19-data-reporting-protocol-version-6-2/2022-12-15T11:36:57+02:00https://primarycare.designagency.gr/severe-acute-respiratory-infections-sari-reporting-protocol-version-3-6/2022-12-15T11:36:57+02:00https://primarycare.designagency.gr/integrated-respiratory-virus-surveillance-respisevere-and-respisurv-data-sets-reporting-protocol-version-1-2/2022-12-15T11:36:57+02:00https://primarycare.designagency.gr/antiviral-resistance-monitoring-capability-and-capacity-for-sars-cov-2-and-influenza-within-the-eu-eea/2022-12-15T17:37:07+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-11-17-december-2022-week-50/2022-12-16T18:34:46+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-18-24-december-2022-week-51/2022-12-22T19:37:27+02:00https://primarycare.designagency.gr/impact-of-surge-in-china-covid-19-cases-on-epidemiological-situation-in-eu-eea/2023-01-03T09:37:03+02:00https://primarycare.designagency.gr/update-on-sars-cov-2-variants-ecdc-assessment-of-the-xbb-1-5-sub-lineage/2023-01-05T17:35:32+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-2-8-january-2023-week-1/2023-01-05T18:34:50+02:00https://primarycare.designagency.gr/easa-ecdc-provide-guidelines-for-aviation-as-part-of-european-response-to-covid-19-developments-in-china/2023-01-11T10:37:08+02:00https://primarycare.designagency.gr/guidelines-in-response-to-the-worsening-of-the-epidemiological-situation-addendum-to-the-aviation-health-safety-protocol/2023-01-11T10:37:08+02:00https://primarycare.designagency.gr/pilot-study-outline-for-targeted-genomic-surveillance-of-sars-cov-2-in-travellers-in-response-to-a-worsening-or-unknown-epidemiological-situation-in-a-third-country/2023-01-13T13:34:56+02:00https://primarycare.designagency.gr/e-learning-case-study-crisis-management-and-communication-during-a-covid-19-outbreak-among-foreign-temporary-workers/2023-01-13T14:37:13+02:00https://primarycare.designagency.gr/e-learning-covid-19-infodemic-management-risk-communication-and-community-engagement-challenges-by-who/2023-01-13T14:37:13+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-9-13-january-2023-week-2/2023-01-13T16:37:21+02:00https://primarycare.designagency.gr/ecdc-assesses-risk-to-the-eu-eea-associated-with-omicron-xbb1-5-sub-lineage/2023-01-13T16:37:21+02:00https://primarycare.designagency.gr/threat-assessment-brief-implications-for-the-eu-eea-of-the-spread-of-the-sars-cov-2-omicron-xbb-1-5-sub-lineage/2023-01-13T16:37:21+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-15-21-january-2023-week-3/2023-01-20T17:37:18+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-23-29-january-2023-week-4/2023-01-27T19:34:45+02:00https://primarycare.designagency.gr/protocol-for-a-covid-19-vaccine-effectiveness-study-using-health-data-registries/2023-01-30T11:37:22+02:00https://primarycare.designagency.gr/core-protocol-for-ecdc-studies-of-covid-19-vaccine-effectiveness-against-hospitalisation-with-severe-acute-respiratory-infection-laboratoryconfirmed-with-sars-cov-2-or-with-seasonal-influenza-versi/2023-01-30T15:37:18+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-30-january-5-february-2023-week-5/2023-02-03T17:34:58+02:00https://primarycare.designagency.gr/considerations-for-infection-prevention-and-control-practices-in-relation-to-respiratory-viral-infections-in-healthcare-settings/2023-02-06T18:36:23+02:00https://primarycare.designagency.gr/healthcare-facilities-should-maintain-and-strengthen-infection-prevention-and-control-measures-during-peaks-of-respiratory-viruses-transmission/2023-02-06T18:36:23+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-week-6-5-11-february-2023/2023-02-10T18:34:50+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-week-7-12-18-february-2023/2023-02-17T17:36:21+02:00https://primarycare.designagency.gr/earthquakes-in-turkiye-and-syria-infectious-diseases-expected-to-be-a-concern-in-two-to-four-weeks/2023-02-20T11:36:22+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-week-8-19-25-february-2023/2023-02-24T16:37:12+02:00https://primarycare.designagency.gr/sars-cov-2-in-animals-susceptibility-of-animal-species-risk-for-animal-and-public-health-monitoring-prevention-and-control/2023-02-28T15:36:26+02:00https://primarycare.designagency.gr/ecdc-de-escalates-ba-2-ba-4-and-ba-5-from-its-list-of-variants-of-concern/2023-03-03T19:37:12+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-week-9-27-february-5-march-2023/2023-03-03T19:37:12+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-week-10-5-11-march-2023/2023-03-10T17:35:20+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-week-11-12-18-march-2023/2023-03-17T18:36:38+02:00https://primarycare.designagency.gr/conducting-after-action-reviews-of-the-public-health-response-to-covid-19/2023-03-21T11:36:33+02:00https://primarycare.designagency.gr/conducting-after-action-reviews-of-the-public-health-response-to-covid-19-update/2023-03-21T11:36:34+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-19-25-march-week-12/2023-03-24T17:37:15+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-week-13-26-march-1-april-2023/2023-03-31T16:36:45+02:00https://primarycare.designagency.gr/interim-public-health-considerations-for-covid-19-vaccination-roll-out-during-2023/2023-04-05T09:35:06+02:00https://primarycare.designagency.gr/autumn-vaccination-campaigns-focused-on-older-age-groups-and-other-high-risk-populations-are-key-to-decrease-impact-of-covid-19/2023-04-05T09:35:06+02:00https://primarycare.designagency.gr/editable-social-media-cards-european-immunization-week-2023/2023-04-21T14:37:23+02:00https://primarycare.designagency.gr/social-media-card-vaccines-for-all-ages/2023-04-21T14:37:23+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-16-22-april-2023-week-16/2023-04-21T16:37:12+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-week-15-9-15-april-2023/2023-04-21T16:37:12+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-23-29-april-2023-week-17/2023-04-28T16:34:46+02:00https://primarycare.designagency.gr/ecdc-presents-lessons-learned-from-the-covid-19-pandemic/2023-05-02T09:34:52+02:00https://primarycare.designagency.gr/lessons-from-the-covid-19-pandemic-may-2023/2023-05-02T10:34:36+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-30-april-6-may-2023-week-18/2023-05-05T16:34:42+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-week-19-7-13-may-2023/2023-05-12T15:34:54+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-7-13-may-2023-week-19/2023-05-12T16:34:58+02:00https://primarycare.designagency.gr/covid-19-vaccination/2023-05-24T09:35:06+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-21-27-may-2023-week-21/2023-05-26T17:35:00+02:00https://primarycare.designagency.gr/clinical-features-and-sequelae/2023-05-30T09:35:01+02:00https://primarycare.designagency.gr/the-pathogen/2023-05-30T09:35:01+02:00https://primarycare.designagency.gr/surveillance/2023-05-30T09:35:01+02:00https://primarycare.designagency.gr/case-definition/2023-05-30T09:35:01+02:00https://primarycare.designagency.gr/public-health-control-measures/2023-05-30T10:35:10+02:00https://primarycare.designagency.gr/case-management-and-treatment/2023-05-30T10:35:10+02:00https://primarycare.designagency.gr/diagnostics/2023-05-30T10:35:10+02:00https://primarycare.designagency.gr/transmission/2023-05-30T10:35:10+02:00https://primarycare.designagency.gr/the-pathogen-2/2023-05-30T10:35:10+02:00https://primarycare.designagency.gr/surveillance-2/2023-05-30T10:35:11+02:00https://primarycare.designagency.gr/case-definition-2/2023-05-30T10:35:11+02:00https://primarycare.designagency.gr/infection-prevention-and-control-in-healthcare-settings/2023-05-30T11:35:02+02:00https://primarycare.designagency.gr/public-health-control-measures-2/2023-05-30T11:35:02+02:00https://primarycare.designagency.gr/case-management-and-treatment-2/2023-05-30T11:35:03+02:00https://primarycare.designagency.gr/transmission-2/2023-05-30T11:35:03+02:00https://primarycare.designagency.gr/clinical-features-and-sequelae-2/2023-05-30T11:35:03+02:00https://primarycare.designagency.gr/the-pathogen-3/2023-05-30T11:35:03+02:00https://primarycare.designagency.gr/factsheet-on-covid-19/2023-05-30T14:35:03+02:00https://primarycare.designagency.gr/infection-prevention-and-control-in-healthcare-settings-covid-19/2023-05-31T14:35:05+02:00https://primarycare.designagency.gr/public-health-control-measures-for-covid-19/2023-05-31T14:35:05+02:00https://primarycare.designagency.gr/case-management-and-treatment-of-covid-19/2023-05-31T14:35:05+02:00https://primarycare.designagency.gr/transmission-of-covid-19/2023-05-31T14:35:05+02:00https://primarycare.designagency.gr/clinical-features-and-sequelae-covid-19/2023-05-31T14:35:05+02:00https://primarycare.designagency.gr/the-pathogen-sars-cov-2/2023-05-31T14:35:06+02:00https://primarycare.designagency.gr/surveillance-of-covid-19/2023-05-31T14:35:06+02:00https://primarycare.designagency.gr/case-definition-for-covid-19/2023-05-31T14:35:06+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-28-may-3-june-2023-week-22/2023-06-02T16:35:05+02:00https://primarycare.designagency.gr/covid-19/2023-06-05T10:35:07+02:00https://primarycare.designagency.gr/ecdc-ema-statement-on-updating-covid-19-vaccines-composition-for-new-sars-cov-2-virus-variants/2023-06-07T10:35:13+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-5-11-june-2023-week-23/2023-06-09T17:35:19+02:00https://primarycare.designagency.gr/questions-and-answers-on-covid-19/2023-06-13T13:35:10+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-11-17-june-2023-week-24/2023-06-16T17:35:02+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-18-24-june-2023-week-25/2023-06-22T16:35:06+02:00https://primarycare.designagency.gr/ecdc-and-easa-formally-retire-joint-aviation-health-safety-protocol-ahsp/2023-06-29T15:37:18+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-25-june-1-july-2023-week-26/2023-06-30T15:34:39+02:00https://primarycare.designagency.gr/generic-protocol-for-covid-19-vaccine-effectiveness-in-preventing-transmission-of-infection-in-healthcare-settings/2023-07-05T10:37:11+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-2-8-july-2023-week-27/2023-07-07T16:37:08+02:00https://primarycare.designagency.gr/sars-cov-2-variant-mutations-conferring-reduced-susceptibility-to-antiviral-drugs-and-monoclonal-antibodies-a-non-systematic-literature-review-for-surveillance-purposes/2023-07-12T13:34:41+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-9-15-july-2023-week-28/2023-07-14T17:34:40+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-16-22-july-2023-week-29/2023-07-21T16:34:51+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-23-29-july-2023-week-30/2023-07-28T18:34:37+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-30-july-5-august-2023-week-31/2023-08-04T16:34:48+02:00https://primarycare.designagency.gr/work-life-balance-during-the-covid-19-pandemic-ecdc-and-eurofound-investigate-the-impact-of-selected-non-pharmaceutical-interventions-in-the-eu/2023-08-09T09:35:12+02:00https://primarycare.designagency.gr/impact-of-selected-non-pharmaceutical-interventions-on-eu-adults-work-life-balance-during-the-covid-19-pandemic/2023-08-09T09:35:12+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-6-12-august-2023-week-32/2023-08-11T17:34:39+02:00https://primarycare.designagency.gr/ecdc-classifies-xbb-1-5-like-lineages-with-the-amino-acid-change-f456l-as-variants-of-interest-following-an-increase-in-sars-cov-2-transmission-in-eu-eea-countries-and-abroad/2023-08-17T17:34:54+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-13-19-august-2023-week-33/2023-08-18T14:34:55+02:00https://primarycare.designagency.gr/coronavirus-disease-2019-covid-19-and-supply-of-substances-of-human-origin-in-the-eu-eea-third-update/2023-08-23T09:34:40+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-20-26-august-2023-week-34/2023-08-25T17:34:50+02:00https://primarycare.designagency.gr/epidemiological-update-covid-19-transmission-in-the-eu-eea-sars-cov-2-variants-and-public-health-considerations-for-autumn-2023/2023-09-08T12:24:48+02:00https://primarycare.designagency.gr/ecdc-publishes-epidemiological-update-on-increased-covid-19-transmission-sars-cov-2-variants-and-public-health-considerations-for-autumn-2023/2023-09-08T12:24:49+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-27-august-2-september-2023-week-35/2023-09-08T12:24:49+02:00https://primarycare.designagency.gr/11o-panellinio-synedrio-thromvosis-antithromvotikis-agogis-2/2023-09-08T13:52:51+02:00https://primarycare.designagency.gr/18o-panellinio-polythematiko-synedrio/2023-09-08T13:53:08+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-10-16-september-2023-week-37/2023-09-15T17:35:09+02:00https://primarycare.designagency.gr/ecdc-director-protect-peoples-health-this-autumn-through-vaccination-and-other-preventive-measures/2023-09-21T16:35:06+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-17-23-september-2023-week-38/2023-09-22T15:35:15+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-24-30-september-2023-week-39/2023-09-29T17:35:18+02:00https://primarycare.designagency.gr/core-protocol-for-ecdc-studies-of-vaccine-effectiveness-against-symptomatic-laboratory-confirmed-influenza-or-sars-cov-2-infection-at-primary-care-level/2023-10-03T10:35:25+02:00https://primarycare.designagency.gr/swedens-advice-making-process-on-schools-during-the-covid-19-pandemic-good-practices-and-lessons-learnt/2023-10-04T10:35:07+02:00https://primarycare.designagency.gr/the-swedish-advice-making-process-for-distance-learning-in-schools-november-2020-%e2%88%92-april-2021/2023-10-04T10:35:07+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-1-7-october-2023-week-40/2023-10-06T15:37:19+02:00https://primarycare.designagency.gr/vulnerable-vaccinate-protecting-the-unprotected-from-covid-19-and-influenza/2023-10-09T09:36:13+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-8-14-october-2023-week-41/2023-10-13T15:37:03+02:00https://primarycare.designagency.gr/evidence-based-advice-processes-for-long-term-care-facilities-in-the-covid-19-pandemic-report-from-the-after-action-review-aar-in-norway/2023-10-17T11:37:08+02:00https://primarycare.designagency.gr/standard-laboratory-protocols-for-sars-cov-2-characterisation/2023-10-18T14:34:34+02:00https://primarycare.designagency.gr/evidence-based-advice-processes-for-long-term-care-facilities-in-the-covid-19-pandemic-aggregate-report-from-the-after-action-reviews-in-georgia-and-norway/2023-10-19T10:37:06+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-15-22-october-2023-week-42/2023-10-20T17:37:12+02:00https://primarycare.designagency.gr/the-european-respiratory-virus-surveillance-summary-erviss/2023-10-25T13:35:23+02:00https://primarycare.designagency.gr/ecdc-and-who-launch-new-surveillance-tool-for-respiratory-viruses-to-improve-early-detection/2023-10-25T13:35:23+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-22-28-october-2023-week-43/2023-10-27T17:35:18+02:00https://primarycare.designagency.gr/reporting-protocol-for-integrated-respiratory-virus-surveillance-v1-1/2023-10-30T14:35:20+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-30-october-11-november-2023-week-45/2023-11-10T15:34:52+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-5-11-november-2023-week-45/2023-11-10T16:39:27+02:00https://primarycare.designagency.gr/communicable-disease-threats-report12-18-november-2023-week-46/2023-11-17T18:39:29+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-19-25-november-2023-week-47/2023-11-24T19:39:31+02:00https://primarycare.designagency.gr/reporting-protocol-for-integrated-respiratory-virus-surveillance-version-1-3/2023-11-28T10:39:33+02:00https://primarycare.designagency.gr/interim-analysis-of-covid-19-vaccine-effectiveness-against-hospitalisation-and-death-using-electronic-health-records-in-six-european-countries/2023-11-30T11:34:35+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-26-november-2-december-2023-week-48/2023-12-01T17:34:40+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-3-9-december-2023-week-49/2023-12-08T18:35:00+02:00https://primarycare.designagency.gr/reporting-protocol-for-integrated-respiratory-virus-surveillance-version-1-4/2023-12-13T14:35:21+02:00https://primarycare.designagency.gr/acute-respiratory-infections-in-the-eu-eea-epidemiological-update-and-current-public-health-recommendations/2023-12-15T13:35:08+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-10-16-december-2023-week-50/2023-12-15T18:35:24+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-17-23-december-2023-week-51/2023-12-22T18:35:16+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-18-25-may-2024-week-21/2024-06-03T13:50:09+02:00https://primarycare.designagency.gr/interim-covid-19-vaccination-coverage-in-the-eu-eea-during-the-2023-24-season-campaigns/2024-06-03T13:50:10+02:00https://primarycare.designagency.gr/weekly-respiratory-virus-update-week-17-april-2024/2024-06-03T13:50:10+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-28-april-4-may-2024-week-18/2024-06-03T13:50:10+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-21-27-april-2024-week-17/2024-06-03T13:50:10+02:00https://primarycare.designagency.gr/weekly-respiratory-virus-update-week-16-april-2024/2024-06-03T13:50:10+02:00https://primarycare.designagency.gr/weekly-respiratory-virus-update-week-15-april-2024/2024-06-03T13:50:10+02:00https://primarycare.designagency.gr/data-on-covid-19-vaccination-in-the-eu-eea-2/2024-06-03T13:50:10+02:00https://primarycare.designagency.gr/surveillance-of-covid-19-in-long-term-care-facilities-in-the-eu-eea-2021-2023/2024-06-03T13:50:10+02:00https://primarycare.designagency.gr/weekly-respiratory-virus-update-week-14-april-2024/2024-06-03T13:50:10+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-1-7-june-2024-week-23/2024-06-07T16:45:43+02:00https://primarycare.designagency.gr/the-advice-making-process-for-school-continuity-in-norwegian-secondary-schools-during-autumn-and-winter-2021/2024-06-20T10:35:53+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-22-28-june-2024-week-26/2024-07-02T11:34:33+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-8-14-june-2024-week-24/2024-07-02T11:34:34+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-25-31-may-2024-week-22/2024-07-02T11:34:34+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-11-17-may-2024-week-20/2024-07-02T11:34:34+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-29-june%e2%88%925-july-2024-week-27/2024-07-05T16:34:39+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-20-26-july-2024-week-30/2024-07-26T16:35:14+02:00https://primarycare.designagency.gr/reporting-protocol-for-integrated-respiratory-virus-surveillance-version-1-6/2024-07-29T11:34:46+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-24-30-august-2024-week-35/2024-08-30T15:42:48+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-31-august-6-september-2024-week-36/2024-09-06T17:34:47+02:00https://primarycare.designagency.gr/reporting-protocol-for-integrated-respiratory-virus-surveillance-version-1-7/2024-09-18T10:36:54+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-21-27-september-2024-week-39/2024-09-27T16:37:47+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-28-september-4-october-2024-week-40/2024-10-04T17:36:11+02:00https://primarycare.designagency.gr/after-action-review-of-the-finnish-advice-making-process-for-school-interventions-during-the-covid-19-pandemic/2024-10-11T09:36:39+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-5-11-october-2024-week-41/2024-10-11T17:37:39+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-12-18-october-2024-week-42/2024-10-18T17:38:44+02:00https://primarycare.designagency.gr/an-updated-framework-for-sars-cov-2-variants-reflects-the-unpredictability-of-viral-evolution/2024-10-23T10:34:57+02:00https://primarycare.designagency.gr/increased-flu-and-covid-19-vaccination-coverage-recommended-for-risk-groups-in-eu-eea-ahead-of-winter-season/2024-10-29T10:52:35+02:00https://primarycare.designagency.gr/covid-19-vaccination-coverage-in-the-eu-eea-during-the-2023-24-season-campaigns/2024-10-29T10:52:35+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-26-october-1-november-2024-week-44/2024-10-31T18:34:57+02:00https://primarycare.designagency.gr/eu-eea-respiratory-virus-network-meeting-2024/2024-11-04T17:36:39+02:00https://primarycare.designagency.gr/weekly-respiratory-virus-update-week-43-october-2024/2024-11-08T17:36:31+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-2-8-november-2024-week-45/2024-11-08T18:37:05+02:00https://primarycare.designagency.gr/weekly-respiratory-virus-update-week-44-october-november-2024/2024-11-12T12:40:03+02:00https://primarycare.designagency.gr/weekly-respiratory-virus-update-week-45-november-2024/2024-11-15T16:34:34+02:00https://primarycare.designagency.gr/european-sars-cov-2-and-influenza-bioinformatics-external-quality-assessment-esib-eqa-2023/2024-11-18T09:35:29+02:00https://primarycare.designagency.gr/weekly-respiratory-virus-update-week-46-november-2024/2024-11-22T17:36:47+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-16-22-november-2024-week-47/2024-11-22T18:36:55+02:00https://primarycare.designagency.gr/weekly-respiratory-virus-update-week-47-november-2024/2024-11-29T17:36:05+02:00https://primarycare.designagency.gr/covid-19-vaccine-effectiveness-against-hospitalisation-and-death-using-electronic-health-records-in-eight-european-countries-in-the-vebis-monitoring-network-october-2023-to-april-2024/2024-12-03T11:39:22+02:00https://primarycare.designagency.gr/reporting-protocol-for-integrated-respiratory-virus-surveillance/2024-12-04T17:39:41+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-30-november-6-december-2024-week-49/2024-12-06T17:36:29+02:00https://primarycare.designagency.gr/weekly-respiratory-virus-update-week-48-november-2024/2024-12-06T17:36:30+02:00https://primarycare.designagency.gr/ecdc-launches-respicompass-a-scenario-modelling-hub-for-respiratory-diseases/2024-12-09T14:39:33+02:00https://primarycare.designagency.gr/weekly-respiratory-virus-update-week-49-december-2024/2024-12-13T17:40:49+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-7-13-december-2024-week-50/2024-12-13T19:36:31+02:00https://primarycare.designagency.gr/core-protocol-for-ecdc-studies-of-vaccine-effectiveness-against-hospitalisation-with-severe-acute-respiratory-infection-laboratory-confirmed-with-sars-cov-2-or-with-seasonal-influenza-version-4-0/2024-12-17T11:34:34+02:00https://primarycare.designagency.gr/acute-respiratory-infections-in-the-eu-eea-epidemiological-update-and-current-public-health-recommendations-winter-2024-2025/2024-12-18T16:43:39+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-14-20-december-2024-week-51/2024-12-20T19:35:44+02:00https://primarycare.designagency.gr/increase-in-respiratory-infections-in-china/2025-01-08T13:38:24+02:00https://primarycare.designagency.gr/weekly-respiratory-virus-update-week-50-december-2024/2025-01-08T14:48:13+02:00https://primarycare.designagency.gr/weekly-respiratory-virus-update-week-1-january-2025/2025-01-10T10:43:27+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-11-17-january-2025-week-3/2025-01-17T18:42:52+02:00https://primarycare.designagency.gr/weekly-respiratory-virus-update-week-2-january-2025/2025-01-20T10:36:00+02:00https://primarycare.designagency.gr/zoonotic-influenza-virus-reporting-protocol-version-2-4/2025-01-21T10:35:09+02:00https://primarycare.designagency.gr/reporting-protocol-for-zoonotic-influenza-virus/2025-01-21T11:35:19+02:00https://primarycare.designagency.gr/relative-effectiveness-of-the-second-booster-covid-19-vaccines-against-laboratory-confirmed-sars-cov-2-infection-in-healthcare-workers-vebis-hcw-ve-cohort-study-1-october-2022-2-may-2023/2025-01-22T15:36:34+02:00https://primarycare.designagency.gr/weekly-respiratory-virus-update-week-3-january-2025/2025-01-24T17:45:52+02:00https://primarycare.designagency.gr/weekly-respiratory-virus-update-week-4-january-2025/2025-01-31T15:35:43+02:00https://primarycare.designagency.gr/weekly-respiratory-virus-update-week-5-february-2025/2025-02-07T16:38:32+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-1-7-february-2025-week-6/2025-02-07T18:45:01+02:00https://primarycare.designagency.gr/weekly-respiratory-virus-update-week-6-february-2025/2025-02-14T16:41:03+02:00https://primarycare.designagency.gr/weekly-respiratory-virus-update-week-7-february-2025/2025-02-21T16:34:34+02:00https://primarycare.designagency.gr/surveillance-report-on-interim-covid-19-vaccination-coverage-in-the-eu-eea-august-2024-january-2025/2025-02-27T10:35:15+02:00https://primarycare.designagency.gr/weekly-respiratory-virus-update-week-8-february-2025/2025-02-28T14:35:19+02:00https://primarycare.designagency.gr/weekly-respiratory-virus-update-week-9-march-2025/2025-03-07T17:37:07+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-1-7-march-2025-week-10/2025-03-07T18:53:36+02:00https://primarycare.designagency.gr/protocol-for-covid-19-vaccine-effectiveness-multi-country-study-vebis-using-health-data-registries-version-3-0/2025-03-12T15:05:09+02:00https://primarycare.designagency.gr/weekly-respiratory-virus-update-week-10-march-2025/2025-03-14T14:30:24+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-8-14-march-2025-week-11/2025-03-14T18:30:43+02:00https://primarycare.designagency.gr/external-quality-assessments-on-covid-19/2025-03-21T13:32:00+02:00https://primarycare.designagency.gr/external-quality-assessment-of-molecular-detection-and-variant-typing-of-sars-cov-2-in-european-expert-laboratories-in-2023/2025-03-21T13:32:00+02:00https://primarycare.designagency.gr/variable-sensitivity-of-sars-cov-2-molecular-detection-in-european-expert-laboratories-external-quality-assessment-june-and-july-2020/2025-03-21T15:31:59+02:00https://primarycare.designagency.gr/external-quality-assessment-of-sars-cov-2-serology-in-european-expert-laboratories-april-2021/2025-03-21T15:31:59+02:00https://primarycare.designagency.gr/external-quality-assessment-of-sars-cov-2-serology-in-european-expert-laboratories-april-2021-2/2025-03-21T15:31:59+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-15-21-march-2025-week-12/2025-03-21T18:32:13+02:00https://primarycare.designagency.gr/weekly-respiratory-virus-update-week-11-march-2025/2025-03-21T18:32:13+02:00https://primarycare.designagency.gr/covid-19-vaccination-reduces-risk-of-long-covid-in-adults/2025-03-25T12:33:14+02:00https://primarycare.designagency.gr/does-covid-19-vaccination-reduce-the-risk-and-duration-of-post-covid-19-condition/2025-03-25T12:33:15+02:00https://primarycare.designagency.gr/weekly-respiratory-virus-update-week-12-march-2025/2025-03-28T17:34:11+02:00https://primarycare.designagency.gr/weekly-respiratory-virus-update-week-13-march-2025/2025-04-04T15:35:37+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-29-march-4-april-2025-week-14/2025-04-04T16:35:43+02:00https://primarycare.designagency.gr/weekly-respiratory-virus-update-week-14-april-2025/2025-04-11T16:37:35+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-19-25-april-2025-week-17/2025-04-25T23:49:31+02:00https://primarycare.designagency.gr/weekly-respiratory-virus-update-week-16-april-2025/2025-04-25T23:49:31+02:00https://primarycare.designagency.gr/weekly-respiratory-virus-update-week-17-april-2025/2025-05-02T13:36:20+02:00https://primarycare.designagency.gr/communicable-disease-threats-report-26-april-3-may-2025-week-18/2025-05-02T17:36:03+02:00https://primarycare.designagency.gr/healthcare-associated-infections-a-threat-to-residents-of-long-term-care-facilities-in-europe/2025-05-05T09:37:57+02:00https://primarycare.designagency.gr/weekly-respiratory-virus-update-week-18-may-2025/2025-05-12T16:42:09+02:00https://primarycare.designagency.gr/weekly-respiratory-virus-update-week-19-may-2025/2025-05-16T15:37:25+02:00